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1. Introduction  
Standard technology for analyte detection in clinical chemistry fields rely on indirect 
characteristics of an analyte, e.g. its absorption capability of light, chemical reactivity or 
physicochemical interaction with macro-molecules as like antigen-antibody interaction. 
Otherwise, analytes are detected directly from molecular characteristics as molecular 
mass and molecular disintegration patterns in mass spectrometric method. Thus, mass 
spectrometric technology are very attractive for the quantification of biomarkers or 
chemicals in the context of diagnostic procedures since those techniques can be provide 
higher quality of analysis of much higher specificity compared to standard technologies 
such as photometry or ligand-binding tests. Even if gas chromatography-mass 
spectrometry (GC-MS) is first introduced mass spectrometric methods to laboratory 
medicine about 40 years ago and provide highly specific and sensitive quantification of 
thermo-stable molecules below a molecular weight of about 500, application of GC-MS 
method remained restricted to few specialized institution in laboratory medicine such as 
mainly toxicology laboratories, medical centres, and reference laboratories. The handling 
and maintenance of GC-MS instruments is very demanding and time-consuming; sample 
preparation is very laborious and includes procedures of sample extraction and analyte 
derivatisations and long run time with a typical sample throughput of less than 50 
samples per day. Over the past decade with introduction of atmospheric pressure 
ionization (API) techniques, liquid chromatography-mass spectrometry (LC-MS) has 
undergone tremendous technological improvement allowing for its applications to 
endogenous components such as proteins, peptides, carbohydrates, DNA, and drugs or 
metabolites. Furthermore, powerful new technologies of ion-analyses (tandem MS, time-
of-flight MS, ion-trap MS) substantially increased the capabilities of MS analyzers with 
respect to specificity and to the extent of data read out. These developments suggest a 
more widespread use of MS techniques superior to other analytical methods in routine 
laboratory medicine. 
The aims of this chapter is to comprehensively characterize the basic principles of mass 
spectrometric detection, recent development of MS, bottleneck of LC-MS method associate 
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with matrix effect, application fields of LC with tandem MS in basic and clinical laboratory 
fields such as drug discovery and development, drug metabolism and toxicology studies, 
quantification of biogenic amines, doping control, TDM and pharmacokinetic (PK) studies. 
2. Basic principles of mass spectrometric detection  
Mass spectrometry (MS) has been described as the smallest scale in the world, not because 
of its size of what it weighs a molecule and a microanalytical technique that can be used 
selectively to detect and determine the amount of a given analyte (Watson & Sparkman, 
2007; Chiu & Muddiman, 2008). MS is also used to determine the elemental composition and 
some aspect of the molecular structure of an analyte. Unique features of MS include its 
capacity for direct determination of the nominal mass of an analyte, and to produce and 
detect fragments of the molecule that correspond to discrete groups of atoms of different 
elements that reveal structure features (Watson & Sparkman, 2007). The tools of MS are 
mass spectrometers, and data are called mass spectra that can be displayed in many 
different ways, which allow the desired information about the analyte to be easily extracted 
(Watson & Sparkman, 2007). A MS is an apparatus which produces a beam of gaseous ions 
from a sample, sorts out the resulting mixture of ions according to their mass-to-charge 
ratios, and provides output signals which are measures of relative abundance of each ionic 
species present. MS are usually classified on the basis of how the mass separation is 
accomplished, but they all can be described as ion optical devices which separate ions 
according to their mass-to-charge (m/z) ratios by utilizing electric and/or magnetic force 
fields (Figure. 1). The concept of MS is to form ions from a sample, to separate the ions 
based on their m/z ratio (this can be considered to be the same as the mass because the ion 
has only a single charge in most cases), and to measure the abundance of the ions. In 
modern MS instrumentation used in environmental analyses, all of the functions (ionization 
separation of the ions, rate of data acquisition, detection of the ions, and storage of the data) 
are under computer control. Gaseous molecules are ionized in the ion source to form 
molecular ions which some of that will fragment. By various processes, ions of differing m/z 
values pass through the mass analyzer one at a time to reach the detector. When the ions 
strike the detector, they are converted into an electrical signal which, in turn, is converted 
into a digital response that can be stored by the computer (Sparkman, 2000).  
A mass specterometer does not directly determine mass but, determines the mass of a 
molecule by measuring the m/z of its ion. The knowledge of the m/z of the ions enables one 
to determine what is present, while the measured ion intensities answer the question of how 
much is present. In addition, systematic interpretation of the mass spectra provides a 
detailed picture of the ionization process which, in turn, may be utilized in the elucidation 
of molecular structures. This definition of the term m/z is important to understanding of MS. 
It should be noted that the m/z value is a dimensionless number that is always used as an 
adjective, e.g. the ions with m/z 256, or the ion has an m/z value of 256. A recording of the 
number of ions (abundance) of a given m/z value as a function of the m/z value is a mass 
spectrum (Watson & Sparkman, 2007). The mass component that makes up the 
dimensionless m/z unit is based on an atomic scale rather than the physical scale normally 
considered as mass. Only ions are detected in mass specterometer and any nonionic 
particles that have no charge are removed from the mass spectrometer by the continuous 
pumping that maintains the vacuum. The MS first must produce a collection of ions in the 
gas phase. These ions are separated according to their m/z values in a vacuum where the 
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Fig. 1. Diagram of mass spectrometer system. 
ions cannot collide with any other forms of matter during the separation process. Ions of 
individual m/z values are separated and detected in order to obtain the mass spectrum. 
Separation of ions in an evacuated environment is mandatory. If an ion collides with 
neutrals in an elastic collision during ion separation process, the ion’s direction of travel 
could be altered and ion might not reach the detector. If an ion’s collision with neutral is 
inelastic, sufficient energy transfer may cause it to decompose, meaning that the original ion 
will not be detected. Close encounters between ions of the same charge can be cause 
deflection in the path of each. Direct contact between ions of opposite charge sign will result 
in neutralization. 
Ions are positively or negatively charged atoms, groups of atoms, or molecules. The process 
whereby an electrically neutral atom or molecule becomes electrically charged, due to losing 
or gaining one or more of its extra nuclear electrons, is called ionization (Chiu & Muddiman, 
2008). Although both positive and negative ions can be analyzed by MS, the majority of 
instruments are used to investigate positive ions because in most ion sources they are 
produced in larger number than negative ions. (Chiu & Muddiman, 2008) 
There is a minimum amount of energy, characterized by the “ionization potential,” that 
must be provided in order for ion formation to occur. The first ionization potential of an 
atom or molecule is defined as the energy input required removing (to infinite distance) a 
valence electron from the highest occupied atomic or molecular orbital of the neutral 
particle to form the corresponding atomic or molecular ion, also in its ground state. When 
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only one electron is removed the ion is called an atomic or molecular ion; often the term 
“parent ion” is used. The formation of parent ions may be considered as ionization without 
cleavage. The numerical magnitude of the ionization potential is influenced by such factors 
as the charge upon the nucleus, the atomic or molecular radius, the shielding effect of the 
inner electronic shells, and the extent to which the most loosely bound electrons penetrate 
the cloud of electric charge of the inner shells (Figure 2).  
 
 
Fig. 2. Ionization potential (http://www.britannica.com/EBchecked/media/647/First-
ionization-energies-of-the-elements). 
Because only ions can be detected in MS, any particles that are not ionic (molecules or 
radicals) are removed from the MS by the continuous pumping that maintains the vacuum. 
When only individual ions are present, they can be grouped according to their unique 
properties (mass and number of charges) and moved freely from one point to another. In 
order to have individual ions free from any other forms of matter, it is necessary to analyze 
them in a vacuum, which means that the ions must be in the gas phase. It is a fundamental 
requirement of MS that ions be in the gas phase before they can be separated according to 
their individual m/z values and detected (Watson & Sparkman , 2007).  
Due to ionization sources such as electrospray ionization (ESI) and matrix-assisted laser 
desorption/ionization (MALDI), MS has become an irreplaceable tool in the biological 
sciences. Over the past decade, MS has undergone tremendous technological improvements 
allowing for its application to proteins, peptides, carbohydrates, DNA, drugs, and many 
other biologically relevant molecules (Chiu & Muddiman, 2008).   
2.1 Instrumentation of mass spectrometric detection  
Mass spectrometry is a particularly powerful scientific technique because it can be 
successfully applied even if you have only a tiny quantity available for analysis—as little as 
10-12 g, 10-15 moles for a compound of mass 1000 Daltons(Da). Compounds can be identified 
through mass spectrometry at very low concentrations (one part in 1012) in chemically 
complex mixtures. The basic mass spectrometry processes of instrumentation are consisted 
of (1) introduction of sample; a sample which can be a solid, liquid, or vapor is loaded onto 
a mass spectrometry device and is vaporized, (2) ionization; sample components are ionized 
by one of several available methods to create ions, (3) analyzer sorting; the ions are sorted in 
www.intechopen.com
Principles and Applications of LC-MS/MS  
for the Quantitative Bioanalysis of Analytes in Various Biological Samples 
 
445 
an analyzer according to their m/z ratios through the use of electromagnetic fields, (4) 
detector; the ions then pass through a detector where the ion flux is converted into a 
propertional electrical current and (5) date conversion; the magnitude of the ion/electrical 
signals is converted into a mass spectrum (Watson & Sparkman , 2007). 
 
  
Fig. 3. Simplified diagram and function of instrumentation of typical mass spectromer  
(Image Source: The University of Hull, Mass Spectrometry Principles and Interpretation, 
Encyclopedia). 
MS instruments consist of three modules: an ion source, which can convert gas phase 
sample molecules into ions (or, in the case of ESI, move ions that exist in solution into the 
gas phase); a mass analyzer, which sorts the ions by their masses by applying 
electromagnetic fields; and a detector, which measures the value of an indicator quantity 
and thus provides data for calculating the abundances of each ion present. The technique 
has both qualitative and quantitative uses. These include identifying unknown compounds, 
determining the isotopic composition of elements in a molecule, and determining the 
structure of a compound by observing its fragmentation. Other uses include quantifying the 
amount of a compound in a sample or studying the fundamentals of gas phase ion 
chemistry (the chemistry of ions and neutrals in a vacuum). MS is now in very common use 
in analytical laboratories that study physical, chemical, or biological properties of a great 
variety of compounds. 
2.2 Basic principles of mass spectrometric detection  
2.2.1 Sample Introduction Techniques  
Sample introduction was an early challenge in MS. In order to perform mass analysis on a 
sample, which is initially at atmospheric pressure (760 torr), it must be introduced into the 
instrument in such a way that the vacuum inside the instrument remains relatively 
unchanged (~10-6 torr). The most common methods of sample introduction are direct 
insertion with a probe or plate commonly used with MALDI-MS, direct infusion or injection 
into the ionization source such as ESI-MS (Chiu & Muddiman, 2008). 
1) Direct insertion: Using an insertion probe/plate is a very simple way to introduce a 
sample into an instrument. The sample is first placed onto a probe and then directly inserted 
into the ionization region of the mass spectrometer, typically through a vacuum interlock. 
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Vaccum interlock allows for the vacuum of the mass spectrometer to be maintained while 
the instrument is not in use. It also allows for the sample (at atomopheric pressure) to be 
introduced into high vacuum of the mass specterometer. The sample is then subjected to any 
number of desorption processes, such as laser desorption or direct heating, to facilitate 
vaporization and ionization. 
2) Direct infusion: A simple capillary or a capillary column is used to introduce a sample as 
a gas or in solution. Direct infusion is also useful because it can efficiently introduce small 
quantities of sample into a mass spectrometer without compromising the vacuum. Capillary 
columns are routinely used to interface separation techniques with the ionization source of 
mass spectrometry. These techniques, including gas chromatography (GC) and liquid 
chromatography (LC), also serve to separate a solution’s different components prior to mass 
analysis. In GC, separation of different components occurs within a glass capillary column. 
As the vaporized sample exits the GC, it is directly introduced into the MS. 
In the 1980s the incapability of LC with MS was due largely to the ionization techniques 
being unable to handle the continuous flow of LC. However, ESI, APCI and atmospheric 
pressure photoionization (APPI) now allows LC/MS to be performed routinely. LC-MS ion 
chromatogram and the corresponding electrospray mass spectrum are typical technique. 
GC-MS produces results in much the same way as LC-MS, however, GC-MS uses an 
electron ionization source, which is limited by thermal vaporization (UV refers to ultraviolet 
and TIC is the total ion current) (Chiu & Muddiman, 2008). 
2.2.2 Ionization method 
Ionization method refers to the mechanism of ionization while the ion source is the 
mechanical device that allows ionization to occur. The different ionization methods work by 
either ionizing a neutral molecule through electron ejection, electron capture, protonation, 
cationization, or deprotonation, or by transferring a charged molecule from a condensed 
phase to the gas phase (Watson & Sparkman, 2007). 
Protonation is a method of ionization by which a proton is added to a molecule, producing a 
net positive charge of 1+ for every proton added. Positive charges tend to reside on the more 
basic residues of the molecule, such as amines, to form stable cations. Peptides are often 
ionized via protonation. Pronation can be achieved via MALDI, ESI, and APCI. 
Deprotonation is an ionization method by which the net negative charge of 1- is achieved 
through the removal of a proton from a molecule. This mechanism of ion-ization, commonly 
achieved via MALDI, ESI, and APCI is very useful for acidic species including phenols, 
carboxylic acids, and sulfonic acids. 
Cationization is a method of ionization that produces a charged complex by non-covalently 
adding a positively charged ion to a neutral molecule. While protonation could fall under 
this same definition, cationization is distinct for its addition of a cation adduct other than a 
proton (e.g. alkali, ammonium). Moreover, it is known to be useful with molecules unstable 
to protonation. The binding of cations other than protons to a molecule is naturally less 
covalent, therefore, the charge remains localized on the cation. This minimizes 
delocalization of the charge and fragmentation of the molecule. Cationization is commonly 
achieved via MALDI, ESI, and APCI. Carbohydrates are excellent candidates for this 
ionization mechanism, with Na+ a common cation adduct. 
The transfer of compounds already charged(=precharged) in solution is normally achieved 
through the desorption or ejection of the positive or negative charged species from the 
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condensed phase into the gas phase. This transfer is commonly achieved via ESI, APCI, FAB 
and MALDI.  
Electron ejection achieves ionization through the ejection of an electron to produce a 1+ net 
positive charge, often forming radical cations. Observed most commonly with electron 
ionization (EI) sources, electron ejection is usually performed on relatively nonpolar 
compounds with low molecular weights and it is also known to generate significant 
fragment ions. It can provide observation of EI and can provide molecular mass as well as 
fragmentation information. However, it often generate too much fragmentation and can be 
unclear whether the highest mass ion is the molecular ion or a fragment. 
With the electron capture ionization method, a net negative charge of -1 is achieved with the 
absorption or capture of an electron. It is a mechanism of ionization primarily observed for 
molecules with a high electron affinity, such as halogenated compounds. It can provide 
observation of electron ionization and can provide molecular mass as well as fragmentation 
information. However, it often generate too much fragmentation and can be unclear 
whether the highest mass ion is the molecular ion or a fragment (Chiu & Muddiman, 2008). 
2.2.3 Ionization sources 
The ion source is the part of the mass spectrometer that ionizes the material under analysis 
(the analyte). Ionization methods include the following; APCI, CI, EI, ESI, fast atom/ion 
bombardment (FAB), field desorption/field ionization (FD/FI), MALDI, thermospray 
ionization (TSP). With most ionisation methods there is the possibility of creating both 
positively and negatively charged sample ions, depending on the proton affinity of the 
sample. Before embarking on an analysis, the user must decide whether to detect the 
positively or negatively charged ions (Ashcroft, 2011). Prior to the 1980s, EI was the primary 
ionization source for mass analysis. However, EI limited chemists and biochemists to small 
molecules well below the mass range of common bio-organic compounds. These techniques 
have revolutionized biomolecular analyses, especially for large molecules. Among them, ESI 
and MALDI have clearly evolved to be the methods of choice when it comes to biomolecular 
analysis. ESI and MALDI are now the most common ionization sources for biomolecular 
mass spectrometry, offering excellent mass range and sensitivity.  
 
 
Fig. 4. A glance at the typical sensitivity and mass ranges allowed by different ionization 
techniques provides a clear answer to the question of which are most useful; EI, APCI and 
DIOS are somewhat limiting in terms of upper mass range, while ESI, nanoESI, and MALDI 
have a high practical mass range (Chiu & Muddiman, 2008). 
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Ion loses between major components of a mass spectrometer are inevitable and occur 
between the source and the analyzer, within the analyzer, and between the analyzer and the 
detector. Atmospheric pressure ion sources, such as encountered with ESI, APCI, APPI, etc., 
present a particular challenge with respect to efficient transfer of ions from the ion source 
into the m/z analyzer. Techniques for ionization have been key to determining what types of 
samples can be analyzed by MS. EI and chemical ionization(CI) are used for gases and 
vapors. Two techniques often used with liquid and solid biological samples include ESI and 
MALDI and these techniques have clearly evolved to be the methods of choice when it 
comes to biomolecular analysis. The idea of ESI, while not new, has been rejuvenated with 
its recent application to biomolecules. 
 
Ionization Source Event 
Electrosray ionization(ESI) Evaporation of charged droplets 
Nanoelectrospray ionization(nanoESI) Evaporation of charged droplets 
Atmospheric pressure chemical ionization 
(APCI) 
Corona discharge and proton transfer 
matrix-assisted laser desorption ionization 
(MALDI) 
Photon absorption/proton transfer 
Desorption/ionization on silicon(DIOS) Photon absorption/proton transfer 
Fast atom/ion bormbardment(FAB) Ion desorption/proton transfer 
Electron ionization(EI) Electron beam/electron transfer 
Chemical Ionization(CI) Proton transfer 
Table X. Summary of event according to ionization sources (Chiu & Muddiman, 2008). 
Inductively coupled plasma (ICP) sources are used primarily for cation analysis of a wide 
array of sample types. In the ion source technology, a 'flame' of plasma that is electrically 
neutral overall, but that has had a substantial fraction of its atoms ionized by high 
temperature, is used to atomize introduced sample molecules and to further strip the outer 
electrons from those atoms. The plasma is usually generated from argon gas, since the first 
ionization energy of argon atoms is higher than the first of any other elements except He, O, 
F and Ne, but lower than the second ionization energy of all except the most electropositive 
metals. The heating is achieved by a radio-frequency current passed through a coil 
surrounding the plasma. Others include glow discharge, field desorption (FD), FAB, 
thermospray, DIOS, Direct Analysis in Real Time (DART), APCI, secondary ion mass 
spectrometry (SIMS), spark ionization and thermal ionization (TIMS) (Bruins, 1991). Ion 
attachment ionization is a newer soft ionization technique that allows for fragmentation free 
analysis (Wikipedia, 2011). 
2.2.4 Mass analyzers 
The m/z analyzer (mass analyzer) is used to separate the ions according to their m/z ratio 
based on their characteristic behavior in electric and/or magnetic fields (Jennings & 
Dolnikowski, 1990; Farmer & McDowell, 1963). MS takes advantages of these different 
behaviors to separate the ions of different m/z values in space or time so that their 
abundances can be determined. Together with the particle's initial conditions, it completely 
determines the particle's motion in space and time in terms of m/q. When presenting data, it 
is common to use the dimensionless m/z, where z is the number of elementary charges (e) on 
www.intechopen.com
Principles and Applications of LC-MS/MS  
for the Quantitative Bioanalysis of Analytes in Various Biological Samples 
 
449 
the ion (z=q/e). This quantity, although it is informally called the m/z ratio, more accurately 
speaking represents the ratio of the mass number, m and the charge number, z. Many MS 
use two or more mass analyzers for tandem MS (MS/MS).  
  With the advent of ionization sources that can vaporize and ionize biomolecules, it has 
become necessary to improve mass analyzer performance with respect to speed, accuracy, 
and resolution. More specifically, quadrupoles, quadrupole ion traps, time-to-flight (TOF), 
time-to-flight reflection (TOFR), and ion cyclotron resonance (ICR) mass analyzers have 
undergone numerous modifications and improvements over the past decade in order to be 
interfaced with MALDI and ESI. In the most general terms, a mass analyzer measures gas 
phase ions with respect to their m/z, where the charge is produced by the addition or loss of 
a proton(s), cation(s), anion(s) or electron(s). The addition of charge allows the molecule to 
be affected by electric fields thus allowing its mass measurement. This is important aspect to 
remember about mass analyzers that they measure the m/z ratio, not the mass itself. 
Multiple charging is especially common with ESI, yielding numerous peaks that correspond 
to the same species yet are observed at different m/z.  
   The performance of a mass analyzers can be typically be defined by the following 
characteristics such as accuracy, resolution, mass range, tandem analysis capabilities, and scan 
speed. Accuracy is the ability with which the analyzer can be accurately provide m/z 
information and is largely a function of an instrument’s stability and resolution. For example, 
an instrument with 0.01% accuracy can provide information on a 1000 Da peptide to±0.1 Da or 
a 10,000 Da protein±1.0 Da. (1) The accuracy varies dramatically from analyzer to analyzer 
depending on the analyzer type and resolution. (2) Resolution so called resolving power is the 
ability of a mass spectrometer to distinguish between ions of different m/z ratios. Therefore, 
greater resolution corresponds directly to the increased ability to differentiate ions. (3) The 
mass range is the m/z range of the mass analyzer. For instance, quadrupole analyzers typically 
scan up to m/z 3000. A magnetic sector analyzer typically scans up to m/z 10,000 and TOF 
analyzers have virtually unlimited m/z range. (4) Tandem MS analysis is the ability of the 
analyzer to separate different molecular ions, generate fragment ions from a selected ion, and 
then mass measure the fragmented ions. The fragmented ions are used to for structural 
determination of original molecular ions. Typically, MS/MS experiments are performed by 
collision of a selected ion with inert gas molecules such as argon or helium, and the resulting 
fragments are mass analyzed. MS/MS analysis is used to sequence peptides, and structurally 
characterize carbohydrates, small oligonucleotides, and lipids. Tandem mass analysis in space 
is performed by consecutive analyzers whereas tandem mass in time is performed with the 
same analyzer, which isolates the ion of interest, fragments it, and analyzes the fragment ions. 
(5) Scan speed refers to the rate at which the analyzer scans over a particular mass range. Most 
instruments require performing a full scan; however this can vary widely depending on the 
analyzer. TOF analyzers, for example, complete analyses within milliseconds or less (Watson 
& Sparkman, 2007; Chiu & Muddiman, 2008). 
2.2.4.1 Sector 
A sector field mass analyzer uses an electric and/or magnetic field to affect the path and/or 
velocity of the charged particles in some way. The sector instruments bend the trajectories of 
the ions as they pass through the mass analyzer, according to their m/z ratios, deflecting the 
more charged and faster-moving, lighter ions more. The analyzer can be used to select a 
narrow range of m/z or to scan through a range of m/z to catalog the ions present (Paul & 
Steinwedel, 1953). 
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2.2.4.2 Time-of-flight (TOF) 
The operating principles of the TOF-MS involve measuring the time required for an ion to 
travel from ion source to a detector usually located 1 to 2 meter from the source (Graff, 1995; 
Guilaus, 1995). The TOF analyzer uses an electric field to accelerate the ions through the 
same potential, and then measures the time they take to reach the detector. If the particles all 
have the same charge, the kinetic energies will be identical, and their velocities will depend 
only on their masses. As the ions traverse the “field-free” region between the ion source and 
detector, they separate into groups or packets according to velocity, which is a function of 
their m/z values, i.e. lighter ions will reach the detector first (March, 2000). As will be seen, 
all other types of m/z analyzers have upper limits for m/z values that can be transmitted and 
separated based on the way the electric and/or magnetic fields are used to separate ions of 
different m/z ratios.  
2.2.4.3 Quadrupole 
Quadrupole mass analyzers use oscillating electrical fields to selectively stabilize or 
destabilize the paths of ions passing through a radio frequency (RF) quadrupole field. Only 
a single m/z ratio is passed through the system at any time, but changes to the potentials on 
magnetic lenses allows a wide range of m/z values to be swept rapidly, either continuously 
or in a succession of discrete hops. A quadrupole mass spectrometer acts as a mass-selective 
filter and is closely related to the quadrupole ion trap, particularly the linear quadrupole ion 
trap except that it is designed to pass the untrapped ions rather than collect the trapped 
ones, and is for that reason referred to as a transmission quadrupole. A common variation of 
the quadrupole is the triple quadrupole. Quadrupoles offer three main advantages such as 
tolerance to relatively high pressures, significant mass range with the capability of analyzing 
up to an m/z 4000, which is useful because ESI of proteins and other biomolecules commonly 
produce charge distributions from m/z 1000 to 3500 and relatively low cost instruments. In 
order to perform tandem MS analysis with a quadrupole instrument, it is necessary to place 
three quadrupoles in series. Each quadrupole has a separate function; the first (Q1) is used 
to scan across a preset m/z range and select an ion of interest. The second (Q2), also known 
as the collison cell, focuses and transmits the ions while introducing a collison gas (argon or 
helium) into the flight path of the selected ion. The third (Q3) serves to analyze the fragment 
ions generated in the collison cell (Q2) (Watson & Sparkman, 2007). 
2.2.4.4 Quadrupole ion trap (QIT) 
The name quadrupole is derived the fact that an electric field is created between four 
opposing electrical poles (Watson & Sparkman, 2007). The QIT works on the same 
physical principles as the quadrupole mass analyzer, but the ions are trapped and 
sequentially ejected. Ions are created and trapped in a mainly quadrupole RF potential 
and separated by m/q, non-destructively or destructively. There are many m/z separation 
and isolation methods but most commonly used is the mass instability mode in which the 
RF potential is ramped so that the orbit of ions with a mass a > b are stable while ions with 
mass b become unstable and are ejected on the z-axis onto a detector. Ions may also be 
ejected by the resonance excitation method, whereby a supplemental oscillatory excitation 
voltage is applied to the endcap electrodes and the trapping voltage amplitude and/or 
excitation voltage frequency is varied to bring ions into a resonance condition in order of 
their m/z ratio (Schwartz et al., 2002; Lammert et al., 2006). Two method of using an ion 
trap for MS are involved to generate ions internally with EI, followed by mass analysis 
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and, more popular method involving in generation of ions externally with ESI or MALDI 
and using ion optics for sample injection into the trapping volume. The QIT typically 
consists of a ring electrode and two hyperbolic endcap electrodes. The isolated ions can 
subsequently be fragmented by collisional activation and the fragments detected. The 
primary advantage of QIT is that multiple collision induced dissociation experiments can 
be performed quickly without having multiple analyzers, such that real time LC-MS/MS 
is now routine. Other important advantages of QIT include their compact size, and thier 
ability to trap and accumulate ions to provide a better ion signal. QIT have been utilized 
in a number of applications ranging from electrospray ionization MS of biomolecules to 
their recent interface with MALDI. LC-MS/MS experiments are performed on proteolytic 
digests which provide both MS and MS/MS information. This information allows for 
protein identification and post-translational modification characterization. The mass 
range (~ m/z 4000) of commercial LC-traps is well matched to m/z values generated from 
the ESI of peptides and the resolution allows for charge state identification of multiple-
charged peptide ions. QIT-MS can analyze peptides from a tryptic digest present at the 
20~100 fmol level. Another asset of the ion trap technique for peptide analysis is the 
ability to perform multiple stages of MS, which can significantly increase the amount of 
structural information. The cylindrical ion trap MS is a derivative of the QIT mass 
spectrometer (Watson & Sparkman, 2007).  
2.2.4.5 Linear quadrupole ion trap (LIT) 
The linear ion trap (LIT), sometimes referred to as the 2-dimensional quadrupole ion trap 
(2D QIT), is one of the more recent additions to the single m/z analyzer group (Douglas et 
al, 2005; Hager, 2002). The LIT makes use of the basic structure of a transmission 
quadrupole; i.e., an array of four electrical surfaces; however, instead of being used to 
filter ions of all m/z values except for those of a desired value from an unresolved ion 
beam, they are used for trapping, manipulation of ion trajectories, and m/z-selective ion 
ejection (Londry & Hager, 2003). A LIT is similar to a QIT, but it traps ions in a 2D 
quadrupole field, instead of a 3-dimensional (3D) quadrupole field as in a 3D QIT. The 
LIT differs from the 3D ion trap as it confines ions along the axis of a quadrupole mass 
analyzer using a 2D radio frequency (RF) field with potentials applied to end electrodes. 
The primary advantage to the linear trap over the 3D trap is the larger analyzer volume 
lends itself to a greater dynamic ranges and an improved range of quantitative analysis 
(Chiu & Muddiman, 2008). This toroidal shaped trap is a configuration that allows the 
increased miniaturization of an ion trap mass analyzer. The LIT has higher injection 
efficiencies and storage capacities than conventional 3D QIT (or Paul trap). 2D multipole 
fields are well known for their capacity to trap and manipulate ions (Gerlich, 1992). Given 
the power of the ion trap the major limitations of this device that keep it from being the 
ultimate tool for pharmacokinetics and proteomics include the following: (1) the ability to 
perform high sensitivity triple quadrupole-type precursor ion scanning and neutral loss 
scanning experiments is not possible with ion traps. (2) The upper limit on the ratio 
between precursor m/z and the lowest trapped fragment ion is ~0.3 (also known as the 
“one third rules”). (3) The dynamic range of ion traps is limited because when too many 
ions are in the trap, space charge effects diminish the performance of the ion trap 
analyzer. To get around this, automated scans can rapidly count ions before they go into 
the trap, therefore limiting the number of ions getting in. Yet this approach presents a 
problem when an ion of interest is accompanied by a large background ion population 
(Chiu & Muddiman, 2008).  
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2.2.4.6 Orbitrap 
The orbitrap mass spectrometer is the latest development in trapping devices used as an m/z 
analyzer. The orbitrap ia a new mass analyzer (Hardman & Makarov, 2003; Hu et al., 2005; 
Makarov et al., 2006); however, it is useful to consider the orbitrap as a modified Knight-
style Kingdon trap with specially shaped inner spindle-like (axial) electrode and a outer 
barrel-like (coaxial) electrodes that form an electrostatic field with quadro-logarithmic 
potential distribution (Makarov, 2000; Makarov et al., 2006a; Hu et al., 2005). The frequency 
of these harmonic oscillations is independent of the ion velocity and is inversely 
proportional to the square root of the mass-to-charge ratio (m/z or m/q). By sensing the ion 
oscillation in a manner similar to that used in Fourier transform ion cyclotron resonance 
(FTICR)-MS, the trap can be used as a mass analyzer. Orbitraps have a high mass accuracy 
(1–2 ppm), a high resolving power (up to 200,000) and a high dynamic range (around 5000) 
(Makarov et al, 2006a; Makarov et al., 2006b). Very similar nonmagnetic FTMS has been 
performed, where ions are electrostatically trapped in an orbit around a central, spindle 
shaped electrode. Mass spectra are obtained by Fourier transformation of the recorded 
image currents. Similar to Fourier transform ion cyclotron resonance mass spectrometers, 
Orbitraps have a high mass accuracy, and high sensitivity and a good dynamic range (Hu et 
al., 2005). 
2.2.4.7 Fourier transform ion cyclotron resonance 
Fourier transform mass spectrometry (FT-MS), or more precisely Fourier transform ion 
cyclotron resonance MS, measures mass by detecting the image current produced by ions 
cyclotroning in the presence of a magnetic field. Instead of measuring the deflection of ions 
with a detector such as an electron multiplier, the ions are injected into a Penning trap (a 
static electric/magnetic ion trap) where they effectively form part of a circuit. Since the 
frequency of an ion's cycling is determined by its m/z ratio, this can be deconvoluted by 
performing a Fourier transform on the signal. FTMS has the advantage of high sensitivity 
(since each ion is "counted" more than once) and much higher resolution and thus precision 
(Comisarow & Marshall, 1974; Marshall et al., 1998). Ion cyclotron resonance (ICR) is an 
older mass analysis technique similar to FT-MS except that ions are detected with a 
traditional detector. Ions trapped in a Penning trap are excited by an RF electric field until 
they impact the wall of the trap, where the detector is located. Ions of different mass are 
resolved according to impact time. 
2.2.5 Detectors 
The final element of the mass spectrometer is the detector that records either the charge 
induced or the current produced when an ion passes by or hits a surface. In a scanning 
instrument, the signal produced in the detector during the course of the scan versus where 
the instrument is in the scan (at what m/q) will produce a mass spectrum, a record of ions as 
a function of m/q (Wikipedia). Typically, some type of electron multiplier is used, though 
other detectors including Faraday cups and ion-to-photon detectors are also used. Because 
the number of ions leaving the mass analyzer at a particular instant is typically quite small, 
considerable amplification is often necessary to get a signal. Microchannel plate detectors 
are commonly used in modern commercial instruments (Dubois et al., 1999). In FT-MS and 
Orbitraps, the detector consists of a pair of metal surfaces within the mass analyzer/ion trap 
region which the ions only pass near as they oscillate. No DC current is produced, only a 
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weak AC image current is produced in a circuit between the electrodes. Other inductive 
detectors have also been used (Park et al., 1994). Sensitivity, accuracy, and response time are 
importantparameters that distinguish different ion detection system (Koppenaal et al., 2005). 
High accuracy and fast-response times usually are mutually exclusive features, therefore, 
the fast-response electron multiplier required to follow rapid scans (e.g. m/z 50 to 500 in 0.1 
sec) probably will not provide the accuracy desired (better than ±0.1 %) in isotope ratio 
measurements. Such isotope ratio measurements are usually made with the Faraday cup 
detector (Nygren et al., 2006; Harris et al., 1984; Mckinney et al., 1950).  Ideally, a statement 
of sensitivity should explicity define the ion current received by detector for a specified rate 
of sample consumption. The definition should include (1) the name of the calibration 
compound, (2) the m/z value of the ion current that is measured, (3) the resolving power of 
the instrument, (4) the quantity of calibration compound consumed per second, (5) the 
intensity of the electron beam and pressure in the ion source for CI, and (6) the ion current 
arriving at the detector (e.g., that impinging the conversion dynode of an electron 
multiplier.  
2.2.5.1 Electron Multiplier (EM) 
The EM uses the principle of secondary-electron emission to effect amplification (Harris et 
al., 1984). Perhaps the most common means of detecting ions involves an EM, which is made 
up of a series (12 to 24) of aluminum oxide (Al2O3) dynodes maintained at ever increasing 
potentials. Ions strike the first dynode surface causing an emission of electrons. These 
electrons are then attracted to the next dynode held at a higher potential and therefore more 
secondary electrons are generated. Ultimately, as numerous dynodes are involved, a 
cascade of electrons is formed that results in an overall current gain on the order of one 
million or higher. The high energy dynode (HED) uses an accelerating electrostatic field to 
increase the velocity of the ions. In the discrete-dynode version of an EM, The ion beam 
from the m/z analyzer is focused onto the conversion dynode, which emits electrons in direct 
proportion to the number of bombarding ions. The secondary electrons from the conversion 
dynode (ions to electrons) are accelerated and focused onto a second dynode, which itself 
emits secondary electrons (electrons to electrons). This means, amplification is accomplished 
through a ‘‘cascading effect“ of secondary electrons from dynode to dynode, because the 
number of electrons impinging on it (Fies, 1988). The efficiency of EM is dependent upon the 
velocity of the impinging particle (Westmacott et al., 2000), a feature responsible for the 
disappointing performance of channel EM arrays in MALDI-TOF/MS for high-mass ions 
(Chen et al., 2003). The secondary electrons are attracted along the positive electrical 
gradient farther on into the cornucopia. Each time these electrons collide with the wall, 
additional secondary electrons are expelled, thereby providing amplification. This form of 
the continuous dynode is curved so as to prevent positive ions from causing spurious 
signals or feedback signals due to seconadry ionization of residue gas molecule (Watson & 
Sparkman , 2007).  
2.2.5.2 Faraday cup 
In this conventional electrical detector, positive ions impinging on the collector are 
neutralized by electrons dawn from groud after passage through a high-ohmic resistor. A 
Faraday cup involves an ion striking the dynode (BeO, GaP, or CsSb) surface which causes 
secondary electrons to be ejected. This temporary electron emission induces a positive 
charge on the detector and therefore a current of electrons flowing toward the detector. This 
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detector is not particularly sensitive, offering limited amplification of signal, yet it is tolerant 
of relatively high pressure (Chiu & Muddiman, 2008). Faraday cup detectors have high 
accuracy, constant sensitivity, and low electrical noise. The principal disadvantage of the 
classical Faraday is tis relatively long time constant inherent in the amplification system 
associated with the use of a high-ohmic resistor in the circuitry (Watson & Sparkman, 2007). 
2.2.5.3 Negative-ion detection  
Modification of a magnetic mass spectrometer to detect negative ions instead of positive 
ions is relatively simple and the polarity of the accelerating voltage and the magnet current 
must be reversed. The negative ions have sufficient injection kinetic energy (typically 3~4 
kV) to impinge on the EM even though it has a negative bias on its first dynode so that 
secondary electrons will experience an overall positive gradient toward the last 
stage(Watson & Sparkman, 2007). In mass spectrometer that uses quadrupole fields no 
change is required in the analyzer part of the instrument because the field acts on positive 
and negative ions equally. In the transmission quadrupole, the repeller and acceleration 
voltages have to be changed from positive to negative. 
2.2.5.4 Post-acceleration detector 
With the advent of the desorption/inonization technique MALDI, it has been possible to 
generate ions of extraordinarily high m/z values, however, it is often difficult to detect such 
ions efficiently because their velocity is relatively low if it depends only on the accelerating 
voltage of the ion source (Beuhler et al., 1991; Matthew et al., 1986). One technique for 
improving the detection efficiency of high m/z value ions is to provide a “post-acceleration” 
electric field to increase their velocity prior to impacting the conversion dynode of the 
detector (Hedin et al., 1987). Detection of macro-ions (those heavier than hundreds of kDa 
having a single or double charge) has been challenge in modern MS. Conventional MS has 
relied on ionization-based detectors, namely those producing and multiplying secondary 
electrons associated with particle bombardment of a metal surface; such detectors are 
restricted to ions having a mass less than 106 Da. An ion-to-proton conversion detector (IPD) 
shows promise for detecting macro-ions (Dubois et al., 1997; Dubois et al., 1999). 
Photosensitive detectors, relying on laser-indued fluorescence (LIF) or elastic light scattering 
(ELS), show promise in this area.  
2.2.5.5 Channel Electron Multiplier Array (CEMA) 
CEMA consists of a honeycomb arrangement of many channels up to several hundred per 
square inch, each having a diameter on the order of 10 μm made possible with fiber optic 
technology using metal-doped glass. A potential difference applied to opposite ends of the 
channels with top and bottom of the honeycomb creates an electrical gradient along the 
resistive but conducting surface of each channel. The ions enter the individual channels 
slightly off-axis so that they impinge the wall of the channel. This primary event (an ion 
colliding with the surface to expel electrons) has very poor efficiency; the efficiency is 
directly proportional to the velocity of the impacting ion, which explains the exceptionally 
poor response of the CEMA to massive ions. The secondary electrons resulting from ions 
impinging the wall continue to ricochet down the channel, producing more secondary 
electrons upon each impact, thereby amplifying the original ion beam (Watson & Sparkman, 
2007). The CEMA is also employed in TOF-MS because it presents a simple flat surface that 
can be arranged perpendicular to the ion beam to preserve velocity resolution of the ion 
packets (Price & Milnes, 1984). 
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2.2.5.6 Photomultiplier conversion dynode 
The photomultiplier conversion dynode detector is not as commonly used at the EM yet it is 
similar in design where the secondary electrons strike a phosphorus screen instead of a 
dynode. The phosphorus screen releases photons which are detected by the photomultiplier. 
One advantage of the conversion dynode is that the photomultiplier tube is sealed in a 
vacuum, unexposed to the environment of the mass spectrometer and thus the possibility of 
contamination is removed. This improves the lifetimes of these detectors over electron 
multipliers. A five-year or greater lifetime is typical, and they have a similar sensitivity to 
the EM (Chiu & Muddiman, 2008). 
2.2.5.7 The daly detector 
The positive ion beam passing the detector slit is attracted toward an aluminized cathode 
(the Daly knob) held at a very large negative potential (e.g. -15,000 V) (Daly et al, 1968a; 
Daly et al, 1968b). Positive ions impacting the Daly knob, which essentially serves ac a 
conversion dynode, produces up to eight secondary electrons, which are attracted to 
scintillator unit held at ground potential. The Daly detector offers two significant 
advantages over other similar detectors. First, most of components (all except the Daly 
knob) are located outside the vacuum chamber, and thus can be served without distrupting 
the pressure regime of the mass spectrometer. Second, the large potential difference used 
between the Daly knob and the slit is particularly advantageous for detecting ions of high 
mass as a post-accelerator detector. In addition, a deceleration lens can be installed in front 
of Daly knob to distinguish between stable ions and those that are ionic products of 
metastable decay (Watson & Sparkman, 2007) 
2.2.5.8 Array detector 
An array detector is a group of individual detectors aligned in an array format. The array 
detector, which spatially detects ions according to their different m/z, has been typically 
used on magnetic sector mass analyzers. Spatially differentiated ions can be detected 
simultaneously by an array detector. The primary advantage of this approach is that, over a 
small mass range, scanning is not necessary and therefore sensitivity is improved ( Chiu & 
Muddiman, 2008). 
2.2.6 Vacuum techniques and systems 
All mass spectrometer need a vacuum to allow ions to reach the detector without colliding 
with other gaseous molecules or atoms. If some collisions between molecules did occur, the 
instrument would suffer from reduced resolution and sensitivity. Low pressure (i.e. 
infrequent ion/molecule or molecule/molecule collisions) is also essential for preservation 
of resolving power in m/z analyzers. Once the direction of an ion’s path has been 
established, any interaction with other matter can cause that direction to change (Watson & 
Sparkman, 2007). One of the first obstacles faced by the originators of mass spectrometer 
was coupling the sample source to a mass spectrometer. The sample is initially at 
atmospheric pressure (760 torr) before being transferred into the mass spectrometer’s 
vacuum (~10-6 torr), which represents approximately a billion-fold difference in pressure. 
One approach is to introduce the sample through a capillary column (GC) or through a 
small orifice directly into the instrument. Another approach is to evacuate the sample 
chamber through a vacuum lock (MALDI) and once a reasonable vacuum is achieved (< 10-2 
torr) the sample can be presented to the primary vacuum chamber (< 10-5 torr). The 
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mechanical pump serves as a general workhorse for most MS and allows for an initial 
vacuum of about 10-3 torr to be obtained. Once a 10-3 torr vacuum is achieved, the other 
pumping systems, such as diffusion, cryogenic and turbomolecular can be activated to 
obtain pressures as low as 10-11 torr (Figure 5) (Chiu & Muddiman, 2008). 
 
 
Fig. 5. A well-maintained vacuum is essential to the function of a mass spectrometer (Chiu 
& Muddiman, 2008). 
2.2.7 Conclusion 
The mass spectrometer as a whole can be separated into distinct sections that include the 
sample inlet, ion source, mass analyzer, and detector. A sample is introduced into the mass 
specterometer and is then ionized. The ion source produces ions either by electron ejection, 
electron capture, cationization, deprotonation or the transfer of a charged molecule from the 
condensed to the gas phase. MALDI and ESI have had a profound effect on mass 
spectrometry because they generate charged intact biomolecules into the gas phase. In 
comparison to other ionization sources such as APCI, EI, FAB, and CI, the techniques of 
MALDI and ESI have greatly extended the analysis capabilities of mass spexterometry to a 
wide range of compounds with detection capabilities ranging from the picomole to the 
zeptomole level. The mass analyzer is a critical component to the performance of any mass 
specterometry. Among the most commonly used are the quadrupole, quadrupole ion trap, 
TOF, TOFR, and FTMS. However, the list is growing as more specialized analyzers allow for 
more difficult questions to be addressed. For example, the development of the quad-TOF 
has demonstrated its superior capabilities in high accuracy tandem mass spectrometry 
experiments. Once the ions are separated by the mass analyzer they reach the ion detector, 
which is ultimately responsible for the signal we observe in the mass spectrum. 
3. Recent development of in high-throughput quantitative bioanalysis by 
liquid chromatography (LC) coupled with mass spectrometry (MS or MS/MS)  
Development of standard techniques of analytical detection in clinical chemistry relies on 
indirect characteristics of an analyte, e.g. its absorption of light, chemical reactivity or 
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physical interaction with macro-molecules (Vogeser & Kirchhoff, 2011). During the past 
decade, LC-MS/MS technologies have substantially extended the methodologic 
armamentarium of clinical laboratories (Vogeser & Seger, 2008). It has become one of the 
essential basic technologies used in laboratory medicine that shown in the analytical 
technology mindmap (Figure 6). 
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Fig. 6. Mindmap for description of analytical technology (www.bene-technology.com). 
In the MS method, in contrast, analytes are detected directly from the molecular 
characteristics as molecular mass and molecular disintegration patterns. Thus, MS 
techniques are very attractive for quantification of biomarkers or xenobiotics in the context 
of diagnostic procedures, since those techniques can enable analyses of much higher 
specificity compared to standard technologies such as photometry or ligand binding tests. 
With GC-MS, first MS was introduced to laboratory medicine about 40 years ago. GC-MS 
allowed the highly specific and sensitive quantification of thermo-stable molecules below a 
molecular weight of about 500 and became a key method in the toxicology field. With the 
respect to standardisation and quality assurance of small molecule analytical routine 
methods the introduction of GC-MS as a reference method was an essential progress, in 
particular for endocrinology. However, for the several reasons the application of GC-MS 
remained restricts too few specialized institution in laboratory medicine including mainly 
toxicological laboratories, metabolism centre, and reference laboratories. The handling and 
maintenance of GC-MS instruments is very demanding and time-consuming; sample 
preparation is very laborious and includes sample extraction and analyte derivatization; the 
analytical run times are long with a typical sample throughput of less than 50 samples per 
day (Vogeser & Kirchhoff, 2011).  
Introduction of API techniques about 20 years ago made practically all potential bio-medical 
analytes amenable for MS. Furthermore, powerful new technologies of ion-analyses (tandem 
MS, TOF-MS, ion-trap MS) substantially increased the capabilities of MS analyzers with 
respect to specificity and to the extent of data read-out in the 1990s. These developments 
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suggested a widespread use of MS methods in routine laboratory medicine. In particular 
tandem MS instruments hyphenated to LC systems used for sample introduction and pre-
fractionation have been implemented in a constantly growing number of clinical 
laboratories worldwide now (Vogeser & Seger, 2008). LC-MS/MS is attractive for laboratory 
medicine for three main reasons. (1) The development of new methods is in general 
straightforward and independent from the diagnostic industry, without the need e.g. to 
develop analytical antibodies. (2) The highly multiplexed analyses are feasible with very 
low current costs; the range of potential analytes is practically unlimited; individual 
“metabolomic analyses” addressing hundreds of analytes from different biochemical 
pathways and from different chemical classes are possible, as well as a comprehensive and 
individual description of xenobiotics (“xenobiom”). (3) When applying the principle of 
isotope dilution internal standardisation, analyses on a reference method-level of accuracy 
can be performed in a routine laboratory setting (Vogeser & Kirchhoff, 2011). LC-MS/MS 
today holds enormous potentials for improvements in the pharmaceutical fields and 
laboratory medicine mainly including TDM, endocrinology, toxicology and metabolomic 
analyses, therefore, hyphenated techniques are examples of new tools that adoped for 
developing fast and cost-effective analytical methods. One of the most prevalent 
hyphenated techniques, LC-MS/MS, has led to major breakthroughs in the field of 
quantitative bioanalysis since the 1990s due to its inherent specificity, sensitivity, and speed. 
It is now generally accepted as the preferred technology for quantitating small molecule 
drugs, metabolites, and other xenobiotic biomolecules in biological matrices as like plasma, 
blood, serum, urine, and tissue (Xu et al., 2007).  
Because samples from biological matrices are usually not directly suitable with LC-MS/MS 
analysis, sample preparation is inevitable and has traditionally been done using protein 
precipitation (PPT), liquid-liquid extraction (LLE), or solid-phase extraction (SPE) processes. 
Manual operations associated with sample preparation are very laborious and time-
consuming. Parallel sample processing in 96-well format using robotic liquid handlers and 
direct injection of plasma using an on-line extraction method have significantly shortened 
the time for analysis and generated a lot of interests in recent years. A major advantage of 
on-line SPE over off-line extraction techniques is that the sample preparation step is 
included into the chromatographic separation and thus eliminates most of the sample 
preparation time classically performed at the bench-side. Fast gradients and short columns 
were first utilized in early applications of high-throughput LC-MS/MS assays to reduce run 
times. Better understanding of how matrix effects can compromise the integrity of 
bioanalytical methods has reemphasized the need for adequate chromatographic separation 
of analytes from endogenous biological components in quantitative bioanalysis using LC-
MS/MS method (Chiu & Muddiman, 2008). 
New developments from chromatographic techniques such as ultra-performance LC with 
sub-2 mm particles and monolithic chromatography are showing promise in delivering 
higher speed, better resolution and sensitivity for high-throughput analysis while 
minimizing matrix effects. On the other hand, automation in LC-MS/MS is great advance in 
instrumentation field and has to address a number of different processes in laboratory 
medicine application of LC-MS/MS that includes management of primary samples, assay-
specific work-up of samples prior to actual MS analysis, integrated control of the subunits of 
the LC-MS/MS systems, processing of primary read-outs, and further handling of result 
data. 
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3.1 Sample preparation 
3.1.1 Basic principles of sample preparation 
Adequate sample preparation is a key aspect of quantitative bioanalysis and can often be the 
cause of bottlenecks during high-throughput analysis. Sample preparation techniques in 96-
well format have been well adopted in high-thoughput quantitative bioanalysis. Four main 
principles of sample extraction are applied in LC: PPT by addition of organic solvents, 
inorganic acids and/or chaotropic salts, protein filtration, LLE, and SPE. Typically not a 
very high degree of protein removal is achieved. The increasing demand for high-
throughput causes a unique situation of balancing cost versus analysis speed as each sample 
preparation technique offers unique advantages. Sample preparation with PPT is widely 
used in bioanalysis of plasma samples. The method has been extended to quantitation of 
drug and metabolites from whole blood. A sensitive and specific LC–MS/MS method for 
the simultaneous determination of cyclosporine A and its three main metabolites (AM1, 
AM4N, and AM9) in human blood have been developed (Koseki et al., 2006). Overall, PPT 
offers a generic and fast sample preparation technique that can be easily automated. 
However, when analyzing supernatant from a plasma sample using PPT, salts and 
endogenous material are still present and cause ion suppression or enhancement that will 
lead to higher variation from sample to sample. Solvent extraction and SPE typically result 
in very clean extracts; ion-suppression effects due to residual matrix components are 
reduced with solvent extraction and SPE compared to mere PPT (Annesley, 2003; Taylor, 
2005). While LLE is predominantly based on differential polarity, a variety of different 
extraction surfaces is available for SPE such as carbohydrates (C2, C8 and C18), ion 
exchange materials (De Jong et al., 2007; De Jong et al., 2010a), phenylic groups, amino 
groups, co-polymer mixed mode materials (Dunér et al., 2007), immobilized on particles 
packed in cartridges. SPE materials can have added particular functions, as removing of 
phospholipids. Both LLE and SPE allow up to ten-fold concentration of analytes; however, 
these methods are technically far more demanding compared to PPT. The optimum choice 
of one of the four main principles of sample preparation is specific for the respective 
analyte, but also for the individual MS/MS system. 
3.1.2 Automated off-line sample preparation 
The most widely used principle for automated sample preparation in LC-MS/MS is so far 
SPE. A wide range of SPE materials is available today and a highly efficient extraction 
protocol can be tailored for practically all analytes by optimizing the content of organic 
solvents, pH or ion strength. The use of SPE often gives superior results to those by a PPT 
method but may not be as cost-effective as PPT due to the labor and material costs 
associated with the process. A novel 96-well SPE plate that was designed to minimize the 
elution volume required for quantitative elution of analytes and the plate was packed with 2 
mg of a high-capacity SPE sorbent that allows loading of up to 750 μL of plasma. The novel 
design permitted elution with as little as 25 μL solvent (Mallet et al., 2003). The evaporation 
and reconstitution step that is typically required in SPE is avoided due to the concentrating 
ability of the sorbent. A sensitive μElution-SPE-LC–MS/MS method were developed for the 
determination of M+4 stable isotope labeled cortisone and cortisol in human plasma (Yang et 
al., 2006).  In the method, analytes were extracted from 0.3 mL of human plasma samples 
using a Waters Oasis HLB 96-well μElution SPE plate with 70 μL methanol as the elution 
solvent. The lower limit of quantitation was 0.1 ng/mL and the linear calibration range was 
from 0.1 to 100 ng/mL for both analytes. A direct coupling of a pre-analytics module 
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directly with a LC-MS/MS instrument is feasible as well, either by a dedicated system 
(Alnouti et al., 2005; Koal et al., 2006) or by implementing a HPLC injection valve onto a 
generic liquid handling system (Daurel-Receveur et al., 2006). A 96-well LLE LC-MS/MS 
method for determination of a basic and polar drug candidate from plasma samples 
developed (Xu et al., 2004). A LLE procedure for sample preparation of dextromethaphan, 
an active ingredient in many OTC regimens, and dextrophan, an active metabolite of 
dextromethaphan in human plasma were reported (Bolden, 2002). Combination of sample 
preparation techniques have been developed to achieve desired sample extract purity with 
high throughput. A simplified PPT/SPE procedure was investiged (Xue et al., 2006). A 
mixture of acetonitrile and methanol along with formic acid was used to precipitate plasma 
proteins prior to selectively extracting the basic drug. After vortexing and centrifugation, 
supernatants were directly loaded onto an unconditioned Oasis MCX μElution 96-well 
extraction plate, where the protonated drug was retained on the negatively charged sorbant 
while interfering neutral lipids, steroids or other endogenous materials were eliminated. 
Additional wash steps were deemed unneccessary and not performed prior to sample 
elution (Xu et al., 2007). However, the system primarily aims to the analysis of research 
samples in micro-vials and is not yet useful for the direct application of standards sample 
containers as used in clinical laboratories. 
3.1.3 On-line solid-phase extraction (SPE) 
The on-line SPE technique offers speed, high sensitivity by the pre-concentration factor, and 
low extraction cost per sample, but typically requires the use of program controlled switch 
valves and column re-configuration. However, the on-line techniques can be fully 
automated and several generic approaches have recently been developed for on-line sample 
extraction coupled to LC-MS (Veuthey et al., 2004; Xu et al., 2005; Zang et al., 2005; Xu et al., 
2006b). Various column demensions can be configured for the fast analysis of drug and their 
metabolites in biological matrix at the ng/mL level or lower. A generic method for the fast 
determination of a wide range of drugs in serum or plasma has been presented for the Spark 
Holland system (Schellen et al., 2003). The method comprises generic SPE with HySphere 
particles, on-line coupled to gradient HPLC-MS/MS detection. The optimized generic SPE-
LC-MS/MS protocol was evaluated for 11 drugs with different physicochemical properties. 
An approach for on-line introduction of internal standard (IS) for quantitative analysis was 
developed on the Spark Holland system (Alnouti et al., 2006). This new technique was 
applied for direct analysis of model compounds in rat plasma using on-line SPE-LC-MS/MS 
quantification. On-line IS introduction allows for non-volumetric sample (plasma) collection 
and direct analysis without the need of measuring and aliquoting a fixed sample volume 
prior to the on-line SPE-LC-MS/MS that enables direct sample (plasma) analysis without 
any sample manipulation and preparation (Koal et al., 2006; Alnouti et al., 2005). On-line 
SPE with high flow rate (normally, 4~6 mL/min) has been achieved by using extraction 
columns packed with large diameter particles. Sample extraction occurs with very high 
solvent linear velocity without significant backpressure. Turbulent flow chromatography 
(TFC) columns marketed by Cohesive Technologies are widely used for this purpose. 
Minimum or no sample pre-treatment is required and significant sample preparation time is 
saved (Chassaing et al., 2005). Another commonly used on-line SPE sorbent material is 
restricted access material (RAM). With a small pore size, RAM works by eliminating the 
access of large molecules such as proteins to the inner surface of the particles, otherwise, 
small molecules can freely bind to the sorbent in the normal hydrophobic interaction mode. 
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Protein molecules quickly pass through the column and are washed out to waste. RAM 
columns have been used as the SPE and analytical column in the single column mode or 
coupled with another analytical column in column-switching mode (Vintiloiu et al., 2005; 
Kawano et al., 2005). A polar functionalized polymer(Strata-X, Phenomenex) has been 
explored as the extraction support in an on-line SPE LC-MS/MS assay that allows direct 
analysis of plasma samples containing multiple analytes (Zang et al., 2005). Beside rapid 
chromatographic seperation, new monolithic-phases have been investigated as extraction 
support for on-line SPE and an good examples of it was automated procedure using on-line 
extraction with monolithic sorbent for pharmaceutical component analysis in plasma by LC-
MS/MS (Xu et al., 2006a). Endogenous materials from urine contains a great deal of amount 
of metabolic products that may present a significant challenge to assay developers and often 
require tedious sample preparation to remove the interfering small molecules. Method 
development for determining drug or metabolite concentrations from urine samples has 
been simplified with the implementation of on-line SPE. A sensitive method using on-line 
SPE and LC-MS/MS system for quantification of urinary cortisol metabolite and cortisol 
was developed and human urine sample were injected directly onto an on-line SPE 
apparatus followed by HPLC separation and LC-MS/MS detection (Barrett et al., 2005). 
3.1.4 New techniques for sample preparations 
While SPE in a 96 position array, PPT in an array, and on-line SPE is used in many clinical MS 
laboratories now, several further methods of sample preparation may become useful for 
clinical LC-MS/MS applications in the future. Some of them are already in environmental and 
food analyses. SPE materials can be packed into pipetting tips; the steps of SPE can be 
performed within these tips by automated pipetting of sample, washing solution and finally 
elution medium with direct injection of the eluate into an injection port (Erve et al., 2009). A 
clear separation between sample preparation and chromatographic fractionation can indeed be 
overcome. A quadrupole TOF-MS was interfaced with a NanoMate system for 
immunosuppressant quantification is described with automated clean-up of the hemolysed 
samples by chromatographic zip-tips and direct injection to an 400 nozzle nano flow-ESI chip 
source without further chromatographic separation (Almeida et al, 2008). SPE materials can be 
packed in permanently used syringes of autosamplers as well and also referred to as solid 
phase micro extraction (SPME) or microextraction by packed sorbents (MEPS) (Blomberg et 
al., 2009; Vuckovic et al., 2010). Reliable methods can be applied in modern high-end 
autosampler devices (e.g., CTC PAL) and can be used an alternative to on-line SPE. 
Ferromagnetic micro-particles with modified surfaces (e.g., C-18 material) might be interesting 
for the automation of sample preparation for LC methods as well (Vogeser et al, 2008). Such 
particles represent a solid phase, however, can be handled in a suspension as a liquid. The use 
of such particles in mass spectrometry might parallel the achievements in the automation of 
heterogonous immunoassays which also require a convenient handling of solid phases. 
Ferromagnetic particles may also be handled within a HPLC system (Vogeser M., 2009). 
Another methods of sample preparation for mass spectrometry also include miniaturized “lab-
on-the-chip” solutions for microfluidic applications (Koster & Verpoorte, 2007).  
3.2. Separation 
3.2.1 Ultra-performance liquid chromatography(UPLC) with sub-2 μm particles 
The use of smaller particles in packed-column LC is a well-known approach to shorten the 
diffusion path for a given analyte. Recent technology advances have made available 
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reverse phase chromatography media with sub-2 μm particle size along with liquid 
handling systems that can operate such columns at much higher pressures. This 
technology termed UPLC, offers significant theoretical advantages in resolution, speed, 
and sensitivity for analytical applications, particularly when coupled with mass 
spectrometers capable of high-speed acquisitions (Xu et al, 2007; Mazzeo et al, 2005). 
Today, two driving forces continue to test the limits of HPLC. One is the need for faster 
separations, such as analyses of either simple samples or a few constituents in a complex 
sample (Romanyshyn, 2001). The second is the desire to achieve greater separation power 
to quantify or identify all the constituents of a complex sample or to compare the contents 
of complex samples with each other (van der Horst & Schoenmakers, 2003; Liu et al. 2002; 
Plumb et al. 2003). The same driving forces resulted in the overwhelming breakthrough in 
the past decade of LC-MS techniques, which continue to spawn new approaches for faster 
or more powerful separations (Niessen, 2003; Tiller et al, 2003). The trend in LC has been 
the continued reduction in particle size. Harnessing the chromatographic potential of sub-
2-μm particles leads to significant improvements in terms of resolution, analysis speed, 
and detection sensitivity. The van Deemter plots for hexylbenzene demonstrate the 
performance improvements that 1.7-μm particles offer over the currently used 5.0- and 
3.5-μm sizes. The 1.7-μm particles give 2~3 x lower plate-height values. The particles also 
achieve the lower plate height at higher linear velocities and over a wider range of linear 
velocities. The result is better resolution and sensitivity as well as reduced analysis time 
(Niessen, 2003; Tiller et al, 2003). In isocratic separations, the resolution is proportional to 
the square root of efficiency. Particle size and efficiency at the optimum linear velocity are 
inversely proportional. Therefore, resolution is inversely proportional to the square root 
of particle size. With this knowledge, we can calculate that 1.7-μm particles will offer 1.7 x 
and 1.4 x greater resolution than 5.0-μm and 3.5-μm particles, respectively, at equal 
column lengths. Because analysis time in isocratic separations is inversely proportional to 
flow rate, 1.7-μm particles offer 1.7 x higher resolution than 5.0-μm particles in a third of 
the time, or 5 x higher productivity (resolution per unit time). The benefit of 1.7-μm 
particles over 3.5-μm ones is 1.4 x higher resolution in half of the time, or 3 x higher 
productivity. More efficient peaks translate to narrower and taller peaks. Peak width is 
inversely proportional to the square root of efficiency; the peak height is inversely 
proportional to peak width. Therefore, when smaller particles are used to make the peaks 
narrower, the peak height is also increased. If the detector is assumed to be concentration-
sensitive (as is the case for UV detectors) and the detector noise remains constant, then 
sensitivity, as defined by S/N, will also increase. Specifically, in comparison with 5.0- μm 
particles, 1.7-μm particles offer 1.7 x higher sensitivity. When compared with 3.5-μm 
particles, 1.7-μm particles provide 1.4 x higher sensitivity for the same column length. 
Several practical issues must be addressed to achieve optimum performance. At constant 
L and optimum flow rate, back pressure is inversely proportional to the third power of dp 
(Martin et al, 1974). Therefore, the 3-fold reduction in dp in UPLC translates to back 
pressures that are 27 x higher compared with HPLC separations when 5-μm particles are 
used. Therefore, UPLC is an exciting new area of LC. A natural extension of HPLC, this 
technique is easy to take full advantage of and requires minimal training. Although we 
have demonstrated the use of UPLC for reversed-phase separations, we expect that it will 
also be beneficial in the areas of normal-phase, hydrophilic interaction and ion-exchange 
chromatographies as well as chiral separation modes that applied for the determination of 
doxazosine in human plasma by UPLC–MS/MS (Al-Dirbashi et al, 2006) and investigated 
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UPLC as an alternative to HPLC for the analysis of pharmaceutical development 
compounds (Wren & Tchelitcheff, 2006). Data on three compounds were presented 
showing that significant reductions in separation time can be achieved without 
compromising the quality of separation. Using a poly-drug reference standard and whole 
blood extracts, the authors successfully separated and identified amphetamine, 
methamphetamine, ephedrine, pseudoephedrine, phentermine, MDA, MDMA, MDEA, 
and ketamine in less than 3 min by the Acquity UPLC-Micromass Quattro Micro API MS 
system (Waters Corporation, USA) (Apollonio et al, 2006). The approach of orthogonal 
extraction/chromatography and UPLC significantly improves assay performance while 
also increasing sample throughput for drug development studies (Shen et al, 2006). Other 
direct comparison experiments using UPLC–MS/MS and HPLC–MS/MS have shown that 
the UPLC–MS/MS improved cycle time by 50–100% with increased sensitivity In the 
study about the differences in LC–MS performance by conducting a side-by-side 
comparison of UPLC for several methods previously optimized for HPLC-based 
separation and quantification of multiple analytes with maximum throughput 
(Churchwell, 2005). Sensitivity increases with UPLC, which were found to be analyte-
dependent, were as large as 10-fold and improvements in method speed were as large as 
5-fold under conditions of comparable peak separations. Improvements in 
chromatographic resolution with UPLC were apparent from generally narrower peak 
widths and from a separation of diastereomers not possible using HPLC. A similar HPLC-
MS/MS quantification protocol was developed for comparison purposes (Yu et al, 2006). 
Both UPLC-MS/MS and HPLC-MS/MS analyses were performed in both positive and 
negative ion modes during a single injection. Peak widths for most standards were 4.8 sec 
for the HPLC analysis and 2.4 sec for the UPLC analysis. Compared with the HPLC-
MS/MS method, the UPLC-MS/MS method offered 3-fold decrease in retention time, up 
to 10-fold increase in detected peak height, with 2-fold decrease in peak width. Limits of 
quantification (LOQ) for both HPLC and UPLC methods were evaluated. 
3.2.2 Monolithic chromatography 
There is considerable interest to improve throughput by using monolithic columns 
because they exhibit higher seperation efficiency at high flow velocities when compared 
to conventional LC columns (Zhou et al, 2005; Ikegami & Tanaka, 2004; Cabrera, 2004; Li 
et al., 2005; Wang et al, 2006).The structural characteristics of the monoliths and those of 
the conventional beds of particular packing materials are very different that are their high 
external porosity resulting from the structure of the network of through macropores and 
the structure of the stationary phase skeleton that consists of a network of small, thin 
threads of porous silica. Two types of monolithic supports are currently available organic 
polymers such as polymethacrylates, polystyrenes, or polyacrylamide and inorganic 
polymers based on silica, carbon and zirconia (Xu et al, 2007). A high-throughput LC-
MS/MS method using a Chromolith RP-18 monolithic column was developed for the 
determination of bupropion, an antidepressant drug, and its metabolites, hydrobupropion 
and threo-hydropupropion in human, mouse, and rat plasma (Borges et al, 2004). The 
monolithic column performance as a function of a column backpressure, peak asymmetry, 
and retention time reproducibility are adquately maintained over 864 extracted plasma 
injections like as a high-througput LC-MS/MS method for the determination of 
methylphenidate (MPH), a central nervous system stimulant, and its de-esterified 
metabolite, ritalinic acid (RA) in rat plasma samples (Barbarin et al, 2003). A monolithic 
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column was directly compared to a conventional C18 column as the analytical column in 
method validation of a drug and its epimer metabilite (Huang et al, 2006). Because the 
chosen drug and its epimer metabolite have same selected reaction monitoring (SRM) 
transitions, chromatographic baseline seperation of these two compounds was required. 
Sample preparation, mobile phases and MS conditions were kept the same in the column 
comparison experiment. The methods on the two systems were found to be equivalent in 
validation parameters and chromatographic seperation, but the monolithic column 
method increased the sample throughput by a factor of two (Xu et al, 2007). The 
significantly improved seperation speed by monolithic columns demanded higher 
throughput on sample extraction. An attractive approach using monolithic separation is 
to combine it with high-flow on-line extraction, which allowed for the fast extraction and 
separation of samples (Zeng et al, 2003; Zhou et al, 2005). A normal phase method on 
silica was adapted for the high-throughput analysis with separations and run times less 
than 1 min. Another high-throughput approach using a monolithic column showed tha 
analysis of over 1100 plasma samples preparaed by PPT in approximately 9 h 
(Mawwhinney & Henion, 2002). Some disadvanages for using monolithic columns for 
high-speed methods have been reported(Chen et al, 2002) that a lack of separation for 
very polar analytes (nicotinic acid and five metabolites) using a monolithic RP-18e 
column.  
3.2.3 Hydrophilic interaction chromatography (HILIC) 
HILIC-MS has been gaining recognition as a valuable technique for analyzing polar 
molecules in biological matrix in recent years (Eerkes et al, 2003; Song et al, 2006; Deng et 
al, 2005). Polar compounds typically have very limited retention on reverse-phase(RP)-
columns. Reverse phased(RP)-HPLC mobile phase with a very low organic content must 
be used to seperate the anlayte from matrix interference. When using ESI-MS, the very 
high aqueous mobile phase can cause low ionization efficiency. The highly volatile 
organic mobile phases used in HILIC provide increased ESI-MS sensitivity. A 
bioanalytical method using automated sample transferring, automated LLE and HILIC-
MS/MS for the determination of fluconazole in himan plasma are developed (Eerkes et al, 
2003). After LLE, the extracts was evaporated to dryness, reconstituted, and injected onto 
a silica column using an acquous-organic mobile phase. The chromatographic run time 
was 2.0 min per injection. The use of HILIC could eliminate the evaporation and 
recostitution steps that hamper improvement of throughput and automation. In a 
validated a single-pot LLE with HILIC-MS/MS method for the determination of 
Muraglitazar, a hydrophobic diabetic drug, in human plasma, organic layer was then 
directly injected into an LC-MS/MS after extraction with acetonitrile and toluene. 
Incomparison with a reversed-phase LC-MS/MS, this single-pot LLE, HILIC-MS/MS 
imporved the detection sensitivity by greater than 4-fold based on the LLOQ signal to 
noise ratio.  
3.2.4 Turbulent flow chromatography 
Turbulent flow chromatography(TFC) is a high flow chromatographic technique, which 
allows high-throughput bioanalysis by requiring little sample preparation and potentially 
fast cycle times. The TFC system takes advantage of unique flow dynamics that allow us 
to analyze compounds in biological matrices with very little sample preparation (Ayton et 
al, 1998). High-throughput LC-MS/MS approaches using TFC employ small internal 
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diameter columns (typically 1 mm or 0.18 μm) with large particles (20~60 μm), which 
allow high flow rates to be utilized without impractical pressure increases. The large 
particles serve to trap the analytes and thus allow unretained compounds to be washed 
out. The resulting trapped analyte is typically eluted onto an analytical column (Ayrton et 
al, 1997). First reports of high-throughput bioanalysis using TFC coupled to MS/MS did 
not use an analytical column but a 50 mm x 1 mm, 50 μm column to perform cleanup and 
analysis that describes the direct analysis of plasma samples using a commercially 
available TFC system; the total run time was 2.5 min, and the method was validated from 
5 to 1000 ng/mL(Ayrton et al, 1997) and later extended the use of “ultra-high flow“ to a 
capillary LC column packed with large particles of 30 μm (Ayrton et al, 1999). Although 
there are advantages in using ultra-high flow on capillary (0.18 mm i.d.) versus narrow 
bore (1.0 mm i.d.) columns, trade offs must be in sample handling, column capacity, and 
robustness. Comparison of the methods showed the LLOQ of the TFC and SPE methods 
was 1 ng/mL; the TFC method used a much smaller plasma aliquot. It should be noted 
that drug B analyzed using a PPT method, which achieved an LLOQ of 0.5 ng/mL 
(Zimmer et al, 1999). In several reports about comparison of methods, these reports show 
that TFC is an attractive approach for high-throughput work involving metabolites 
(Ramos et al, 2000; Lim et al, 2001; Hopfgartner et al, 2002; Herman, 2002). Commercial 
systems are available which acommodate 1 to 4 seperate TFC systems and one mass 
spectrometer (Berna et al, 2004).    
4. Bottlenecks of liquid chromatography with mass spectrometric method 
associate with matrix effect 
4.1 What is the matrix effect? 
HPLC-MS/MS detection has been demonstrated to be a powerful technique of choice for 
the quantitative determination of drugs and metabolites in biological fluids (Matuszewski 
et al, 2003; Taylor, 2005a; Kebarle & Tang, 1993). However, the common perception that 
utilization of HPLC–MS/MS guarantees selectivity has been challenged by a number of 
reported examples of lack of selectivity due to ion suppression or enhancement caused by 
the sample matrix (Clarke et al, 1996; Buhrman et al, 1996; Matuszewski et al, 2003) and 
interferences from metabolites (Constanzer et al, 1997; Jemal & Xia, 1999). The central 
issue is what experiments, in addition to the validation data usually provided for 
bioanalytical methods, need to be conducted to demonstrate the absence of a relative 
(“lot-to-lot”) matrix effect and to confirm HPLC–MS/MS assays selectivity. Matrix effects 
occur when molecules coeluting with the compounds of interest alter the ionization 
efficiency of the electrospray interface. The matrix effects is probably originates from the 
competition between an analyte and the coeluting, undetected matrix components. Matrix 
effects are the result of competition between nonvolatile matrix components and analyte 
ions for access to the droplet surface for transfer to the gas phase (King et al, 2000). Better 
understanding of how matrix effects can compromise the integrity of bioanalytical 
methods has re-emphasized the need for adequate chromatographic separation of 
analytes from endogenous biological components in quantitative bioanalysis using LC–
MS/MS (Xu et al, 2007). Inherent specificity of LC–MS/MS methods results in 
chromatograms that do not present any apparent interference, although relatively high 
concentrations of matrix components are sometimes present (Hernández et al, 2005). 
Matrix effects are also compound-dependent and the chemical nature of a compound has 
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a significant effect on the degree of matrix effects (Bonfiglio et al, 1999). In a study of 4 
compounds of different polarities under the same mass spectrometric conditions, the most 
polar was found to have the largest ion suppression and the least polar was affected less 
by ion suppression. These findings of differential matrix effects have important 
ramifications particularly when selecting a suitable IS for quantification purposes. For 
example, if a drug and a glucuronide metabolite were quantified by IS against a close 
analogue of the parent drug and matrix effects were slightly different between samples, 
then the change in ionization of the more polar glucuronide metabolite would probably 
not be compensated by the IS. Thus if there are multiple analytes to be quantified, with 
varying degrees of polarity, there may be requirements for multiple IS (Lagerwerf et al, 
2000). The importance of matrix effects on the reliability of HPLC–ESI–MS/MS has been 
shown in terms of accuracy and precision (Matuszewski et al, 1998), and when ion 
suppression occurs, the sensitivity and lower limit of quantification of a method may be 
adversely affected (Buhrman et al, 1996). Thus to develop a reliable HPLC–ESI–MS/MS 
method, experiments should be performed to understand these matrix effects by careful 
consideration to evaluate and eliminate matrix effects. 
4.2 Evaluation of matrix effects 
The two main techniques used to determine the degree of matrix effects on an HPLC–ESI–
MS/MS method are postextraction addition and postcolumn infusion. The postextraction 
addition technique requires sample extracts with the analyte of interest added 
postextraction compared with pure solutions prepared in mobile phase containing 
equivalent amounts of the analyte of interest (Annesley, 2003; Matuszewski et al, 2003; 
Matuszewski, 1998). The difference in response between the postextraction sample and 
the pure solution divided by the pure solution response determines the degree of matrix 
effect occurring to the analyte in question under chromatographic conditions. The post-
column infusion method provides a qualitative assessment of matrix effects, identifying 
chromatographic regions most likely to experience matrix effects (Bonfiglio et al, 1999). 
Any endogenous compound that elutes from the column and causes a variation in ESI 
response of the infused analyte is seen as a suppression or enhancement in the response of 
the infused analyte (Bakhtiar & Majumdar, 2007; Bonfiglio et al, 1999). This approach, 
however, does not provide a quantitative understanding of the level of matrix effect 
observed for specific analytes. In addition, if several compounds are determined in one 
method, all compounds should be infused separately to investigate possible matrix effects 
for every analyte. Therefore, matrix effects are not investigated for lower than LLOQ. In 
contrast, the post-extraction spike method quantitatively assesses matrix effects by 
comparing the response of an analyte in neat solution to the response of the analyte 
spiked into a blank matrix sample that has been carried through the sample preparation 
process (Matuszewski et al, 2003; Chambers et al, 2007). The absolute matrix effect was 
defined as the comparison of the signal response of a standard present in a sample extract 
from one single lot to the response of a standard in neat solution. However, even more 
important is the evaluation of the relative matrix effect, which is the comparison of matrix 
effect values between different lots of biofluids and therefore proposed that matrix effects 
should be investigated in biofluid samples from at least five different sources 
(Matuszewski et al, 2003). In a more recent paper, they have suggested to use the 
precision of the calibration line slopes in five different lots of a biofluid as an indicator of 
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relative matrix effects. The relative standard deviation should not exceed 3–4% for the 
method to be considered practically free from relative matrix effects (Matuszewski, 2006). 
Recently, Heller presented a new concept, namely matrix effect maps, for visualizing the 
impact of various parameters on matrix effects associated with a given method. In this 
approach matrix effects are studied as a function of the amount of co-injected matrix 
extract (Heller, 2007). In Heller's approach, two sets of mixtures were prepared in 
different formats and, to provide different matrix effect conditions for testing these 
mixtures, chromatographic conditions were altered as well. Furthermore, operational 
variables like desolvation gas flow and temperature could also be included in these matrix 
effect maps. However, these issues remain to be fully tested. In the future, this approach 
could help to determine the ruggedness of a developed method. 
4.3 Methodology to overcome matrix effects 
Different actions can be taken to overcome matrix effects. Matrix effects may be reduced by 
simply injecting smaller volumes or diluting the samples, which is useful as long as 
instrumental sensitivity remains adequate (Heller, 2007). Other possibilities to reduce or 
eliminate matrix effects are the optimization of sample preparation and/or chromatographic 
parameters (Xu et al, 2007; Hernández et al, 2005; Niessen et al, 2006). Another approach is 
the use of an internal standard (IS) to compensate for the alteration in signal. If sensitivity is 
not an issue, an alternative ionization source, less sensitive to matrix effects, can be used, 
e.g. APCI (Chambers et al, 2007) or electron ionization. In many cases, several approaches 
are combined to achieve adequate quantitative results (Niessen et al, 2006). Because the 
presence of coeluting compounds cause matrix effect, there is need to remove or minimize 
their presence to obtain a robust LC-MS/MS. 
4.3.1 Sample preparation techniques 
In general, matrix effects may be reduced by simply injecting smaller volumes or diluting 
the sample. However, these solutions will clearly influence the sensitivity of the method and 
are therefore in many cases not appropriate (Antignac et al, 2005). Proper sample clean-up is 
therefore of primordial importance. Even if PPT is the simplest and fastest method for 
preparing samples, however, it does not result in a very clean extract and is most likely to 
cause ion suppression in ESI. Co-elution of these compounds with the compound of interest 
affects the ESI droplet desolvation process (Dams et al, 2003; Bakhtiar & Majumdar, 2007; 
Chambers et al, 2007). In comparison with PPT, the extracts obtained from SPE are relatively 
cleaner (Bakhtiar & Majumdar, 2007; Chambers et al, 2007). LLE often yields rather clean 
extracts, but the procedures are usually cumbersome and have many pitfalls. Multiple 
extraction steps are commonly needed to increase analyte recovery and to obtain cleaner 
extracts (Jessome & Volmer, 2006). Supported LLE can be used to decrease sample 
preparation time and improve analyte recovery. Rapid extraction of analyte occurs during 
this intimate contact between the two immiscible phases. The solvent moves through the 
packing by gravity flow or use of a gentle vacuum(Majors, 2006). 
4.3.2 Chromatographic sepreration 
Improved chromatography is a straightforward way to separate interfering compounds 
from analytes. Gradient elution can help to wash the column after injection and prevent late-
eluting compounds from the previous injection to interfere. If the analytes are ionizable, the 
www.intechopen.com
 
Tandem Mass Spectrometry – Applications and Principles 
 
468 
pH of the mobile phase can have a significant impact on the retention, selectivity and 
sensitivity of the separation (Chamber et al, 2007). It was also shown that fast gradient LC 
promotes matrix effects by reducing chromatographic separation between analytes and 
endogenous compounds. If high throughput is required, effective sample pretreatment 
becomes critical, since the chromatographic conditions are not able to reduce matrix effects. 
Another possibility is the use of a stationary phase with a different selectivity, for example 
hydrophilic-interaction liquid chromatography (HILIC). HILIC which combines the use of 
bare silica or polar bonded stationary phases and mobile phases with a high content of 
organic solvents, has been proven to be a valuable tool for the analysis of polar compounds 
in biological samples (Ji et al, 2008). UPLC retains the practicality and principles of classical 
LC, but increases the speed, resolution and sensitivity of the method by using columns with 
small diameter (1.7-μm) particles and high pressures. The improved resolution might 
provide a benefit with respect to matrix effects, through improved separation from 
endogenous components and obtained a statistically significant reduction in matrix effects 
under a variety of chromatographic conditions and with multiple basic analytes, using the 
UPLC technology (Chambers et al, 2007). 
4.3.3 Mass spectrometric analysis 
APCI-MS is less susceptible to matrix effects than ESI-MS and, however, the occurrence of 
matrix effects has also been shown with APCI (Dams et al, 2003; Sangster et al, 2004; Niessen 
et al, 2006). In addition, the APCI interface was more susceptible to matrix effects than the 
ESI interface for the same instrument. Even with this source, matrix effects were observed 
for most analytes and internal standards at all concentrations tested, with values ranging 
from 85.2 to 149.4% (Mei et al, 2003). Miniaturized ESI methods are proven to be more 
tolerant towards contaminations in the analyte solution. Dialysate matrix effects were 
estimated at different concentration levels of oxcarbazepine and its major metabolite, using 
a column switching microbore, capillary and nanoLC–MS/MS system (Lanckmans et al, 
2006). Only at the lowest level of the microbore system, a significant matrix effect was 
observed. Since a lower flow rate reduces the size of the charged droplets, fewer droplet 
fission events and less solvent evaporation are required for ion release in the gas phase. This 
leads to a reduction in contaminant concentration(Lanckmans et al, 2006; Schmidt et al, 
2003). The ionization suppression caused by matrix effects after plasma or urine injection 
have been observed in a conventional restricted-access media-LC system (Georgi & Boos, 
2006), in contrast, assaying similar compounds with a capillary chromatographic setup, such 
matrix effects were not present and this attribute to the better characteristics of ESI-MS/MS 
under low flow rate (Santos-Neto et al, 2008). The extent of matrix effects also depends on 
the source design of the LC–MS system used. In some cases, problems observed with matrix 
effects can be solved by using a MS instrument from another manufacturer (Niessen et al, 
2006; Mei et al, 2003). Regarding the ionization polarity, the negative mode is usually 
considered as more specific and consequently less subjected to ion suppression, but in 
practice, this is of course not possible for all analytes. (Antignac et al, 2005; Niessen et al, 
2006). 
4.3.4 Role of internal standard  
As IS either a structural analogue or a stable isotope labeled-IS can be applied. However, 
the ionization of the analogue IS and the analyte may be differently affected by the matrix. 
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This can be solved by using a stable isotope labeled-IS which co-elutes with the drug, 
since matrix effects should not affect the relative efficiency of ionization of the drug and 
its stable isotope labeled-IS. The stable isotope labeled-IS are compounds in which several 
atoms in the analyte are replaced by their stable isotopes, such as 2H (D), 13C, 15N or 17O 
with 2H being the most frequently used isotope. It is important that the mass difference 
between the analyte and the stable isotope labeled-IS is at least 3 mass units (Stokvis et al, 
2005), in order to avoid signal contribution of the abundance of the natural isotopes to the 
signal of the IS. If the compound and IS are not separated adequately by mass, this will 
result in quadratic standard curves (http://www.ionsource.com/tutorial/msquan). 
However, issues like isotopic purity of compounds, cross-contamination and cross-talk 
between MS/MS channels, isotopic integrity of the label in biological fluid and during 
sample processing, etc. should be carefully addressed (Matuszewski et al, 2003). The 13C, 
15N or 17O-labeled IS may be more ideal than the 2H- labeled ones, since deutrium and 
hydrogen have greater differences in their physical properties than for example 12C and 
13C (Wang et al, 2007). It is of primordial importance to choose an appropriate IS during 
method development and to closely monitor the method performance in routine use, since 
only limited lots of biological matrix are tested during method validation (Wang et al, 
2007). If ion suppression significantly reduces the signal of analyte and/or of the IS, the 
signal to noise may decrease to a poit where accuracy and precision may be negatively 
affected (Annesley, 2003). Even if this is not always practically feasible, a number of 
labeled IS identical to the number of compounds to be analyzed would be required 
(Hernandez et al, 2005). 
4.3.5 Matrix effect on the biological method validation 
Studies about matrix effects in quantitative bioanalysis revealed that the ion suppression 
or ion enhancement is frequently accompanied by significantly deterioration of the 
precision and accuracy of the method. The precision, expressed as relative standard 
deviation, is plotted as a function of the analyte concentration. While for a single plasma 
lot the precision is acceptable, this is not the case when five different lots of plasma are 
taken into account (Matuszewski et al, 2003; Niessen et al, 2006). An absolute matrix 
effects on the other hand will primarily affect the accuracy of the method (Matuszewski et 
al, 2003). Even if matrix effects can be compensated by an appropriate IS, efforts should be 
made to eliminate these co-eluting compounds, since their presence will be reduce 
mathod sensitivity. When analyzing low concentrated samples, this can lead to false 
negative results. Biofluids such as plasma and especially urine represent highly complex 
matrices and its composition can be various significantly between individuals and species, 
but also within an individauls (Georgi & Boos, 2006). Most method validations are 
performed using calibration standards and QC samples prepared from the same pool of 
blank matrix. Using these homogenous samples for validation does not take into account 
the inter-and intrapatient matrix variability (Taylor, 2005a). Checking the quality of an 
assay using QC samples, which are prepared in the same matrix as calibration standards, 
will not reveal matrix effects observed in the incurred samples (Dewe et al, 2007). 
Repetitive analysis incurred samples is one of the best strategies to evaluate any hidden 
analytical effect in the method. While it is not practical to prepare calibration standards 
and QC standards for each individual matrix source, some assessment of patients 
variability must be undertaken (Taylor, 2005b).  
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5. Application of LC-MS/MS in basic and clinical laboratory fields 
5.1 LC-MS/MS in drug metabolism & toxicology studies 
Studies of the metabolic fate of drugs and other xenobiotics in living systems may be 
divided into three broad areas such as qualitative studies for elucidation of metabolic 
pathways through identification of circulatory and excretory metabolites, quantitative 
studies for determination of pharmacokinetics of the parent drug and/or its primary 
metabolites, and mechanistic studies for identification of chemically-reactive metabolites, 
which play a key role as mediators of drug-induced toxicities. The mass spectrometry has 
been regarded as one of the most important analytical tools in studies of drug metabolism, 
pharmacokinetics and biochemical toxicology. With the commercial introduction of new 
ionization methods such as API techniques and the combination of LC-MS or LC-MS/MS, it 
has now become a truly indispensable technique in pharmaceutical research. Triple stage 
quadrupole and ion trap mass spectrometers are presently used for this purpose, because of 
their sensitivity and selectivity. API-TOF mass spectrometry has also been very attractive 
due to its enhanced full-scan sensitivity, scan speed, improved resolution and ability to 
measure the accurate masses for protonated molecules and fragment ions (Kamel & 
Prakash, 2006). The study of the metabolic fate of drugs is an essential and important part of 
the drug development process. The analysis of metabolites is a challenging task and several 
different analytical methods have been used in these studies. However, after the 
introduction of the API technique, ESI and APCI, LC-MS has become an important and 
widely used method in the analysis of metabolites owing to its superior specificity, 
sensitivity and efficiency. Among the pharmacokinetic properties, metabolic 
characterization is a key issue and nowadays it is integrated into the early discovery phase. 
Biotransformation can lead also to some unwanted consequences, such as rapid clearance of 
the drug from the body, formation of active metabolites, drug–drug interactions due to 
enzyme induction or competition and formation of reactive or other toxic metabolites 
(Gibson & Skett, 1994). Metabolic pathways are divided into phase I and phase II reactions, 
and both classes of reaction often occur in parallel for particular compounds. The 
information required to determine the metabolic fate of an NCE includes detection of 
metabolites, structure characterization and quantitative analysis. Since the introduction of 
the ESI and APCI techniques, LC/MS has become an ideal and widely used method in the 
analysis of metabolites owing to its superior specificity, sensitivity and efficiency (Sinz & 
Podoll, 2002). API techniques are compatible with reversed-phase eluent systems, taking 
into account the use of volatile solvents and additives in chromatographic separation, thus 
preserving all the advantages of LC. Together, ESI and APCI provide efficient ionization for 
very different type of molecules including polar, labile, and high molecular mass drugs and 
metabolites (Kostiainen et al, 2003). Most work in metabolite analysis is carried out by using 
triple-quadrupole mass spectrometers (QQQ), as their MS/MS scan types (Schwartz et al, 
1990) are highly helpful in the identification of metabolites and provide the required 
specificity and sensitivity (Clarke et al, 2001). Product ion scans are used for identification 
and MRM provides the high sensitivity required in quantitative analysis. The unique feature 
of QQQ is its capability to identify families ofmetabolites by using neutralloss and precursor 
ion scans.33 However, the sensitivity of identification of metabolites by the full-scan mode 
may not always suffice and instead of QQQ the use of IT and TOF-MS has increased. Both of 
these techniques provide high full-scan sensitivity. In addition, modern IT-MS technology 
with its MSn (Schwartz et al, 1990) capability is highly efficient in the structural analysis of 
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metabolites. The API-TOF mass spectrometry provides high-resolution analysis with a mass 
accuracy better than 10 ppm, and hence the possibility of the determination of the elemental 
compositions of metabolites and high specificity in their detection. (Zhang et al, 2000a; 
Zhang et al, 2000b). Furthermore, the quadrupole-TOF mass spectrometer (Q-TOF) provides 
high sensitivity for the determination of full-scan product ion spectra of metabolites (Zhang 
et al, 2000a). The first step in metabolite profiling for dertection of metabolitea and 
deferentiation of the site of biotransformation is to identify all the possible metabolites. The 
second step is their structural characterization and finally quantitation. The classical method 
in metabolic analysis is radioactive labeling (14C, 3H) of a parent drug and detection of 
metabolites by LC with radioactivity detection (Veltkamp et al, 1987; Egnash & 
Ramanathan, 2002). Themethod is especially powerful when combinedwith on-line MS 
detection. Radioactivity detection provides localization of the metabolites in a 
chromatogram and MS ensures structure specific identification of the metabolites. However, 
this approach has several disadvantages. For example, synthesis and purification of 
radioactive compounds are expensive and time-consuming, radiation is a potential health 
risk for humans and the requirements for handling radioactive material and wastes make 
the use of radiolabeled compounds very costly. For these reasons and the fact that 
radioactively labeled compounds are only very rarely available in early discovery phase, 
different, simpler, MS techniques are increasingly used in metabolite identification 
(Kostiainen et al, 2003). MS/MS offers more specific detection of metabolites in complex 
matrices than unit resolution full-scan MS. MS/MS scanning methods include product ion, 
precursor ion and neutral loss scans (Schwartz et al, 1990). Metabolites are derivatives of the 
parent drug and as such it can be assumed that many of the metabolites show the same 
fragment ions or neutral losses as the parent drug. Therefore, the precursor ion and neutral 
loss scan modes with QQQ are especially useful in group-specific detection of metabolites 
(Clarke et al, 2001). To overcome the problems in metabolic analysis, new technologies are 
continuously being developed. The recently introduced LC-MS/NMR technology provides 
unambiguous structure characterization of metabolites. Although the sensitivity of NMR 
does not suffice for the analysis of metabolites in trace quantities, the sensitivity of the 
technology is continuously being improved. The use of standards or radiolabeled 
compounds in quantitative analysis and thus the time-consuming synthesis step of reference 
compounds can be avoided, when on-line coupling of LC-MS to detection techniques that 
provide equimolar responses, such as ICP-MS or chemiluminescent nitrogen detection, are 
used. Microfluidic systems offer possibilities to integrate all the experimental steps of 
metabolite analysis on one microchip, providing complete analysis steps (e.g. sample 
pretreatment, chemical reactions, analytical separation, and detection and data processing 
steps) on a single device with a high level of automation. Progress in microfluidics gives 
reason to assume that the metabolite analysis will be carried out by miniaturized lab-on-a-
chip techniques integrated with miniaturized mass spectrometers in the near future 
(Kostiainen et al, 2003). 
5.2 LC-MS/MS as quantification method for biogenic amines 
The term biogenic amines refer to amine containing biogenic substrates such as 
catecholamines, serotonin and histamine. Biogenic amines function throughout the body, 
both in the central and peripheral nervous system. Disorders affecting their metabolism or 
action can have devastating effects on homeostasis of the human body (Hyland, 1999). In 
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clinical chemistry quantification of biogenic amines is mainly used for diagnosis of 
neuroendocrine tumors such as pheochromcytoma and carcinoids. HPLC coupled tandem 
MS is becoming an indispensible technique in the special chemistry laboratories in clinical 
chemistry as it greatly increases sensitivity and specificity of test results. Applying this 
technique will result in improved biochemical diagnosis of endocrine disorders, and opens 
new roads to gain insight in pathophysiological processes. For the measurement of biogenic 
amines in biological matrices, LC-MS/MS needs to compete with conventional HPLC with 
UV, fluorescence or ECD and to a lesser extend GC methods and immunoassay (Yi & 
Brown, 1991). In pharmaceutical industries and toxicology laboratories, LC-MS/MS is the 
method of choice for the development and the measurement of drugs (Maurer, 2007). For 
clinical chemical analyses LC-MS/MS is rapidly emerging and is applicable to a broad 
selection of compounds, especially for the diagnosis of aberrations within the endocrine 
system, such as biogenic amines (Chan et al, 2000; Kushnir et al, 2002; Lionetto et al, 2008; de 
Jong et al, 2008; de Jong et al, 2009a), but also steroids (Soldin and Soldin, 2009), thyroid 
hormones (Yue et al, 2008), and vitamin D (Higashi et al, 2008). Furthermore LC-MS/MS 
enable the use of sophisticated sample pretreatment techniques and automation of the 
whole process by on-line coupling of the separate techniques. To correct for losses during 
sample pretreatment, analyte separation and detection, stable isotopes of analytes are used 
as internal standard with mass spectrometry. LC-MS/MS combines the physical separation 
capabilities of HPLC with the high analytical sensitivity, specificity and accuracy of mass 
spectrometric detection. In recent years, LC-MS/MS equipment has been improved in 
performance. Due to its superior specificity, shorter runtimes and less laborious sample 
preparation, LC-MS/MS methods replace more and more of the conventional HPLC, GC-
MS and immunoassay techniques (Taylor, 2005b; Vogeser & Seger, 2008b; Maurer, 2007). 
LC-MS/MS has, just as HPLC and GC-MS, the advantage that several compounds can be 
measures simultaneously (Holst et al, 2007). 
Introduction of on-line solid-phase extraction coupled to LC-MS/MS shortened 
chromatographic run times and allowed automation of sample preparation (de Jong et al, 
2007). Urinary deconjugated metanephrines have been analyzed with LC-MS/MS for many 
years. Since these markers occur in higher concentration ranges and require less sensitive 
assays. Catecholamines assist in the diagnosis of neuroendocrine catecholamine-producing 
tumors, such as pheochromocytoma and neuroblastoma, in addition to metanephrine and 
HVA (Lenders et al, 2002; Sawka et al, 2003). Recently, an on-line SPE LC-MS/MS method 
has been described for catecholamines in urine, especially improving specificity, sensitivity 
and run time compared to the conventional HPLC-ECD method used on the same 
laboratory (de Jong et al, 2010a). 
Serotonin in blood is mainly stored in platelets. Free serotonin occurs in low concentrations 
in plasma because of active reuptake and fast metabolism which complicates detection with 
most conventional techniques (de Jong et al, 2011). Platelet serotonin is specifically 
measured for the detection of carcinoid tumors that secrete little serotonin. With LC-
MS/MS, it is possible to measure accurate and reproducible serotonin both in platelet-rich 
and plasma-poor plasma (de Jong et al, 2009b; Monaghan et al, 2009; de Jong et al, 2010b). 
For this purpose, protein precipitation, using acetonitrile, combined with chromatography 
based on strong cation exchange and reversed-phase interaction, was used with a total run 
time of 6 min (Monaghan et al, 2009) and a detection limit of 5 nmol/L. Solid phase 
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extraction based on weak cation exchange and HILIC, comparable to the method described 
for plasma metanephrines, resulted in the same run time with detection limits even below 1 
nmol/L (de Jong et al, 2010). Therefore, LC-MS/MS is becoming an indispensible tool for 
low-molecular weight biomarker quantification also in the field of special clinical chemistry. 
It overcomes drawbacks of conventional techniques, such as long analysis times and chance 
of interferences, has a broad analyte compatibility and high analytical performance. It 
enables more sensitive and specific measurement of biogenic amines and metabolites, and 
the routine quantification of biomarkers in low concentration ranges. 
5.3 Usefulness of LC-MS/MS in doping control 
LC-MS(/MS) has become an integral part of modern sports drug testing as it offers unique 
capabilities complementing immunological and GC-MS(/MS)-based detection methods for 
prohibited compounds. The improved options of fast and sensitive targeted analysis as well 
as untargeted screening procedures utilizing high resolution/high accuracy MS have 
considerably expanded the tools available to anti-doping laboratories for initial testing and 
confirmation methods. One approach is to focus on preselected target analytes that are 
measured with utmost specificity and sensitivity using diagnostic precursor–product ion 
pairs in low resolution tandem mass spectrometers. The other scenario is to measure and 
plot extracted ion chromatograms of protonated or deprotonated molecules as well as 
product ions as recorded in the full scan mode with high resolution/high accuracy MS 
(Thevis et al, 2011). 
For modern doping control laboratories, the use of LC-MS(/MS) has become obligatory to 
meet the needs of fast, robust, sensitive, and specific detection methods in sports drug 
testing. GC with or without low or high resolution GC-MS held a superior position in 
routine doping controls until almost the end of the last century, and various analytical 
challenges such as those presented by heavy volatile or polar target analytes were 
successfully overcome, e.g., by means of sophisticated derivatization strategies; a few 
aspects, however, remained unsolved by mass spectrometry, particularly concerning high 
molecular weight analytes. In addition, the demands with regard to time and manpower as 
well as the necessity to use hazardous derivatizing reagents in some applications have 
further strengthened the position of LC-MS(/MS) in the sports drug testing arena 
(Hemmersbach, 2008; Thevis & Schänzer, 2007). Traditionally, most of test methods in 
doping control laboratories were established for urine samples as dictated by the class of 
analytes, e.g., one assay for stimulants, one for narcotics, one for anabolic-androgenic 
steroids, etc., because most of these compounds within one category share common 
physicochemical properties. Because derivatization and structure-specific pre-concentration 
and purification are not mandatory anymore for a considerable number of analytes that are 
detectable by LC-MS(/MS) at relevant concentration levels, screening procedures have 
become (at least partly) independent of such groupings and allow comprehensive analyses 
within significantly shortened analytical times. Nevertheless, besides its enormous value for 
doping control purposes, the complementary strategy of LC-MS(/MS) bears its own 
challenges such as the needs to account for positive and negative ionization, the generation 
of multiply charged ions (particularly with molecules of higher molecular mass) and, 
consequently, adequate identification criteria, as well as the higher susceptibility of LC-
MS(/ MS) to ion suppression/matrix effects compared to GC-MS(/MS) methods.  
With the constantly improving resolving power of modern LC systems and enhanced 
robustness and sensitivity of tandem mass spectrometers interfaced with atmospheric 
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pressure ionization, a considerable trend towards multianalyte testing procedures with or 
even without prior sample preparation and purification steps has been recognized. This 
trend is evidenced by a variety of earlier studies, the common goal of which was the 
increase of sample throughput, thus meeting the constantly growing demands concerning 
the implementation of new drugs, short reporting times, and cost-effectiveness (Thevis et al, 
2011). Following an established extraction protocol based on alkaline (pH=9.5), LLE of urine 
with diethyl ether, ultrahigh-performance liquid chromatography (UHPLC) and MS/MS 
with scan-to-scan polarity switching was employed for the combined analysis of 34 target 
compounds, namely 25 diuretics, 5 stimulants, and 4 other substances (Ventura et al, 2008). 
Using a comparable instrumental setup composed of a 2.1×50 mm BEH C-18 column (1.7-
μm particle size), gradient elution with 10 mM ammonium acetate (solvent A) and methanol 
(solvent B), and scan-to-scan polarity switching, a total of 133 target analytes directly from 
diluted urine were measured (Thörngren et al, 2008). The target analytes were 37 diuretics 
and masking agents, 24 narcotics, and 72 stimulants, all of which were analyzed in a total 
runtime of 7.5 min with LODs between 1 and 50 ng/mL (i.e., well below the corresponding 
MRPLs) while a minimum of 10 data points/peak was maintained. Considering the rapid 
(and automated) sample preparation and very short runtimes, a high-throughput option for 
initial doping control tests is provided. As an alternative to targeted MRM analyses, the use 
of high resolution/high accuracy mass spectrometry as a screening tool for sports drug 
testing purposes has been thoroughly investigated and initial studies and approaches were 
successfully pursued. One of the major advantages of these procedures over purely targeted 
measurements with dedicated and fixed ion transitions is the complete collection of raw 
data, which provides the retrospective option to mine the analytical data for formerly 
unknown compounds as well as new drugs when they become relevant for doping controls. 
Because the International Standard for Laboratories (ISL) allows forre-processing and re-
analysis of doping control samples (that were initially reported negative) in the case of new 
relevant information, the evaluation of electronic data is a fast and cost-effective means to 
filter the enormous amount of samples for those being suspicious in light of new intelligence 
(World Anti-Doping Agency, 2011). The combined use of considerably improved 
instrumental options has initiated the development of a variety of multi-analyte test 
methods in sports drug testing laboratories and these assays cover a great variety of 
compounds with highly diverse physicochemical properties. 
Conventional HPLC was still in use in the cases of several low resolution mass 
spectrometry-based approaches, whereas procedures relying on high resolution/high 
accuracy mass spectrometry used either monolithic columns or UHPLC capable stationary 
phases to fully exploit the analytical power provided by these technologies. The strategy to 
investigate the metabolic fate of therapeutics as well as non-approved designer drugs in a 
doping control context deviates slightly from clinical settings.  
Analytical goals of sports drug testing usually involve the long-term detection of drug 
administration, most often targeting inactive metabolites. However, temporal indications of 
drug abuse are supportive in order to distinguish between long-term and acute use, e.g., 
when only the in-competition use of the drug is prohibited. LC-MS(/MS) has been an 
integral part of sports drug testing efforts for more than a decade, and the continuously 
improving instrumentation with a gradually expanding number of supportive features has 
considerably enhanced the quality and speed of doping control analysis for low and high 
molecular weight compounds (Thevis et al, 2011). 
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5.4 LC-MS/MS in therapeutic drug monitoring for immunosuppressants  
The outcome of post-transplantation patient care has been improved dramatically over the 
last decades, primarily due to the availability of appropriate immunosuppressive regimens 
(Yang et al., 2005). The immunosuppressants present toxicity and have narrow therapeutic 
ranges. For example, CsA showed numerous side effects including immunological, renal, 
hepatic and neurological complications, requiring dose adjustments or discontinuations in a 
significant percentage of patients (Rezzani, 2004). In addition, blood levels of the active 
drugs vary significantly in different individuals and ethnicities as well as different 
combinations of immunosuppressants (Holt, 2002; Yang et al, 2005). Therefore, the success 
of the post-transplant patient care largely depends on optimization of immunosuppressive 
therapy based on routine therapeutic drug monitoring (TDM). The available analytical 
methods for monitoring immunosuppressant levels in patient specimens can be divided into 
two categories: immunoassays, such as microparticle enzyme immunoassay (MEIA), 
enzyme multiplied immunoassay technique (EMIT), fluorescent polarization immunoassay 
(FPIA), cloned enzyme donor immunoassay (CEDIA), and liquid chromatography-based 
methods (Yang et al, 2005). Immunoassays are widely employed to measure mycophenolic 
acid (MPA, active metabolite of MMF), CsA, tacrolimus, and sirolimus in human blood or 
serum/plasma. Chromatography-based methods include high performance liquid 
chromatography (HPLC) with ultraviolet detection, HPLC-MS, and HPLC-MS/MS. HPLC-
MS/MS has gained increasing popularity in clinical laboratories due to the advantages of 
the technology over other methods while the capital cost for instruments has been decreased. 
HPLC-MS/MS provides high specificity and sensitivity for the above mentioned 
immunosuppressants. In addition, HPLC-MS/MS is able to simultaneously measure several 
drugs and/or their major metabolites in one single analytical run. The combination of HPLC 
and MS has revolutionized the analytical society during the past decades (Wilson & 
Brinkman, 2003). MS measures the abundance of charged particles based on mass over 
charge ratio (m/z). MS/MS technique utilizes multiple (two or more) MS with collision cell 
in between resulting in improved specificity by providing characteristic molecular 
fragments (fingerprints) generated by collision-induced dissociation. Because of high 
specificity of MS/MS detection, the baseline separation of target compounds from their 
potential interferents by HPLC, which is a must for many HPLC-UV or HPLC-MS assays, 
becomes unnecessary leading to significant savings in analytical time, sample purification 
effort and chemical reagents. Usually a typical HPLC-MS/MS run can be accomplished 
within a few minutes in immunosuppressant monitoring (Yang et al., 2005; Ceglarek et al., 
2006). In addition MS/MS can measure multiple ions or transitions to determine multiple 
drugs in a single analytical run. Like any other technique, however, HPLC-MS/MS has its 
own limitations. HPLC-MS/MS instruments require high initial capital investment and need 
highly trained analysts to appropriately operate and maintain the systems. Thus HPLC-
MS/MS instruments are only available in a limited number of clinical laboratories. The most 
widely used ESI source for MS/MS is vulnerable to ion suppression (Annesley, 2003), which 
could lead to significant sensitivity loss and erroneous results. Ion suppression occurs when 
co-eluting compounds suppress the ionization of the target compounds in the ionization 
sources. One effective way to eliminate ion suppression is to remove extraneous matrix 
components through sample cleanup procedures. However, it adds extra time and effort 
that many clinical laboratories cannot afford. In addition, HPLC-MS/MS is not completely 
immune to interferences caused by isomers or isobaric molecules (Vogeser & Spohrer, 2005). 
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There have been a few new HPLC-MS/MS methods developed in recent years to measure 
single immunosuppressive drug in patient specimens, including sample types other than 
blood, plasma or serum. There are also recent development on application of new 
technologies in immunosuppressant TDM including sample preparation and ionization 
(Yang & Wang, 2008). Dried blood spot sampling is an alternative to venous blood sampling 
for immunosuppressant TDM due to the convenient sample collection from fingerprick and 
small blood volume collected. A preliminary investigation of an HPLC-MS/MS assay of 
tacrolimus in dried blood spot formed on sample paper by fingerprick blood sampling was 
reported (Hoogtanders et al., 2007a). There was no significant bias observed for dried blood 
sampling compared to venous blood sampling using 34 samples in 26 stable renal transplant 
outpatients measured by HPLC-MS/MS (Hoogtanders et al., 2007b). Because of various 
targets of action from different immunosuppressants, combinations of immunosuppressants 
are often used together to achieve synergistic therapeutic effects with reduced toxicity (Yang 
et al., 2005). Therefore, it is ideal to simultaneously measure these drugs in one analytical 
run. A rapid HPLC-MS/MS method was developed for determination of MPA and MPAG 
in plasma using the same sample preparation and HPLC-MS/MS conditions as used in 
simultaneous measurement of CsA, tacrolimus, sirolimus, and everolimus in whole blood 
(Ceglarek et al., 2006). For the practical issues with application of HPLC-MS/MS in 
immunosuppressant monitoring, Internal standards should be carefully selected when 
using HPLC-MS/MS to measure immunosuppressants, because they are critical to 
compensating for sample preparation variations, ionization efficiency differences, and 
matrix effects with MS/MS detection. The ideal internal standards are isotope-labeled target 
compounds, which have the exact same physical and chemical properties as the target 
compounds. In many cases, however, the isotope-labeled compounds are not always 
available and the alternative structural analogues should be considered and evaluated 
carefully before use including the consideration of inter-subject differences(Taylor, 2007). 
Nine commercial methanol used in HPLC eluting solvents were evaluated for signal 
suppression of sirolimus, tacrolimus, and MPA in MS/MS detection (Annesley, 2007). 
Product ion intensity was found to vary by 10 folds among the methanol tested. Though 
appropriate internal standards could compensate for the signal loss, performance of the 
assay (e.g., LLOQ) could be compromised. Therefore, HPLC-MS/MS continues being 
considered as the method of choice in TDM of immunosuppressants due to its high 
sensitivity and specificity while random access immunoassays, though may give significant 
different results compared to HPLC-MS/MS, also play an important role in this area. 
However, one should carefully select the internal standards and organic solvents used in 
HPLC-MS/MS method and evaluate their effects on the assay performance prior to 
implementation of an HPLC-MS/MS method. 
6. Conclusion  
In this chapter, we reviewed basic principles and most recent advances of LC-MS/MS 
methdology including sample preparation, seperation and MS/MS detection and 
appications in the several areas such as quantification of biogenic amines, pharmacokinetic 
and TDM for immunosuppresants and doping control. Until now, together with 
advancement including automation in the LC-MS/MS instrumentations along with pararell 
sample processing, column switching, and usage of more efficient supports for SPE, they 
drive the trend towards less sample clean-up times and total run times–high-throughput 
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methodology-in today’s quantitative bioanalysis area. Newly introduced techniques such as 
ultra-performance liquid chromatography with small particles (sub-2μm) and 
monolithicchromatography offer improvements in speed, resolution and sensitivity 
compared to conventional chromatographic techniques. Hydrophilic interaction 
chromatography (HILIC) on silica columns with low aqueous/high organic mobile phase is 
emerging as a valuable supplement to the reversed-phase LC–MS/MS. Sample preparation 
formatted to 96-well plates has allowed for semi-automation of off-line sample preparation 
techniques, significantly impacting throughput. On-line SPE utilizing column-switching 
techniques is rapidly gaining acceptance in bioanalytical applications to reduce both time 
and labor required producing bioanalytical results. Extraction sorbents for on-line SPE 
extend to an array of media including large particles for turbulent flow chromatography, 
restricted access materials (RAM), monolithic materials, and disposable cartridges utilizing 
traditional packings such as those used in Spark Holland systems. Also this chapter also 
discusses recent studies of evaluation and overcome of matrix effect in LC–MS/MS analysis 
and how to reduce/eliminate matrix effect in method development and validation and 
clinical applications in the several areas as like biogenic amines analysis, therapeutic drug 
monitoring of immunosuppressant and doping control. 
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